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Abstract 
 
 
The aim of this thesis was to determine whether the addition of dithiothreitol 
(DTT) treatment and LIVE/DEAD cell differential staining in the current 
protocols used for assessment of sperm DNA fragmentation and oxidative DNA 
damage, will improve the detection of sperm DNA damage. Investigations were 
also undertaken to determine the levels of oxidised nucleic acids in seminal 
plasma and blood serum as indicators of local and systemic oxidative stress; 
and to explore the relationships between these parameters and the outcome of 
assisted reproduction. 
 
A total of 92 patients undertaking their third cycle or less for either an 
Intrauterine Insemination (IUI) or an In vitro Fertilisation/Intra-Cytoplasmic 
Sperm Injection (IVF/ICSI) treatment were recruited for the study. 
Assessment of percentage sperm DNA fragmentation was performed using the 
terminal deoxynucleotidyl transferase (TdT)-mediated 
deoxyuridinetriphosphate (dUTP) nick-end labeling (TUNEL) assay in all 
cases, using an existing protocol that was implemented in a clinical setting by 
Dr Laura Surmon. The assessment of oxidative DNA damage was determined 
using the percentage 8-oxo-7, 8- dihydro-2’ deoxyguanosine (8OHdG) as the 
biomarker, a fluorescence-labeled 8OHdG- specific protein and a protocol 
designed by Dr Laura Surmon. 
 
The method involved taking approximately 200µl of spermatozoa prepared for 
treatment that had a concentration of at least 10 million/ml. Both assays were 
performed simultaneously using the current protocol assay with the updated 
protocol assay i.e. the addition of DTT and LIVE/DEAD stain for sperm DNA 
fragmentation and oxidative sperm DNA damage. Seminal plasma was also 
collected and used for mass spectrometry (MS) analysis as an indicator of the 
levels of oxidative stress local to the male reproductive tract. Although seminal 
plasma contains very low levels of DNA when compared to spermatozoa itself, 
isolating DNA and RNA in sperm cells was not necessary since the TUNEL and 
8OHdG assays already assess this. The study was focusing on isolating the fluid 
component in particular, to localise the source of oxidative stress. 
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Furthermore, a sample of blood was also collected from the male on the day of 
treatment and the serum isolated and used for MS to determine levels of 
systemic oxidative stress. Of the 92 patients recruited for the study only 78 
were included. Sample size was restricted due to a number of male patients not 
consenting to providing a blood sample on the day of treatment and some 
samples containing RNA and/or DNA at levels below that detectable by MS. 
 
Of the 78 patients however, 25 patients had an IUI cycle and 53 patients 
underwent an IVF/ICSI cycle. There were no significant differences between 
the IUI and IVF/ICSI treatment groups in terms of male or female age, or the 
presence of a significant female infertility factor or abnormal semen 
parameters on the day of treatment. 
 
There were no significant differences between the current and updated assay 
protocols which included DTT and LIVE/DEAD stain in terms of percentage 
sperm DNA fragmentation (TUNEL) or oxidative sperm DNA damage (8OHdG). 
However there was a noticeable effect when DTT was applied in the updated 
assay, which seemed to have made the sperm heads swell and therefore 
identifying each sperm cell became more complex. Further work needs to be 
done to experimentally determine how DTT may best be incorporated into the 
assays to increase access to DNA damage while also limiting the disruption to 
the spermatic cell membrane and thus maintaining overall cell and assay, 
integrity. 
 
The percentage of sperm DNA damage as determined using the TUNEL assay 
was found to be significantly lower on the day of treatment as compared to 
the time of initial semen analysis. It is possible that the course of antioxidants 
prescribed by the medical director, has led to a reduction in the degree of DNA 
damage in the form of DNA strand breaks by the time of treatment. Such 
reductions may therefore mean that the less invasive IUI cycle may become an 
option for previously unsuitable patients. 
 
This study has also demonstrated a significant correlation between seminal 
plasma levels of oxidised nucleic acids and sperm DNA fragmentation (r = 
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0.457, p < 0.05), which suggests that sperm DNA damage may be due to 
oxidative stress in the male reproductive tract rather than systemic oxidative 
stress as addressed in results. Ongoing investigations need to be done to 
confirm these findings and further explore the role of 8OHdG and sperm DNA 
fragmentation in fertility and their impact on the outcome of assisted 
reproduction. 
 
In terms of the outcome of assisted reproduction following IUI (n = 25), the 
mean percentage sperm DNA fragmentation as determined using the current 
TUNEL assay protocol was significantly lower for those couples achieving a live 
birth (2.5% vs 10.3%, p < 0.001). Through receiver operating characteristic 
(ROC) analysis, a threshold of 3.5% sperm DNA fragmentation was shown to 
have a good sensitivity and specificity for predicting an outcome of a live birth 
following an IUI in this subset of patients. A threshold <3.5% was also 
associated with higher pregnancy and decreased miscarriage rates. 
 
In conclusion, there is no evidence from this study to suggest that DTT and/or 
LIVE/DEAD should be routinely incorporated into existing TUNEL or 8OHdG 
assays. In fact, the incorporation of the LIVE/DEAD stain demonstrated that 
very few non-viable sperm cells remain following density gradient 
centrifugation (DGC), thus increasing confidence in the reliability of the results 
obtained using these assays. Further work needs to be done however, on 
optimising the addition of DTT to assays for assessment of sperm DNA damage 
due to the effect of DTT on overall cell integrity, with cell swelling making 
assessment difficult. 
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1. Research Theme/Question 
 
 
The term ‘infertility’ is used when the ability to become pregnant is diminished 
or absent. It does not necessarily mean that you are unable to have children but 
that you may require treatment or assistance to achieve a pregnancy. The term 
infertility is generally used if a couple has not conceived after 12 months, or 
after six months for women aged 35 (Gnoth et al. 2005), of regular, unprotected 
intercourse. It is a relatively common condition affecting approximately one in 
every six couples (Gnoth, et al. 2005). Traditionally, it has been thought of as a 
female problem, however this is far from the truth. In the vast majority of 
infertile couples, defective sperm function is a factor and in fact is held to be the 
largest single and defined cause of human infertility (Aitken et al. 2014). 
 
While the rate of infertility has not increased in recent years, we are now more 
aware of the issue as more and more women and men are seeking treatment. 
Many couples who have difficulty conceiving may have a specific medical 
condition that is hindering the woman’s ability to become pregnant (Speroff et 
al. 2005). In 40% of cases the issue is attributable to the female, while in 40% of 
cases it can be traced back to the male. As for the rest of the cases, fertility 
problems remain unexplained or may be linked to both partners, resulting in 
both requiring some form of treatment (Speroff et al. 2005). 
 
A rising cause of infertility is the female age as many couples are delaying 
having children . Women’s fertility begins to diminish (the quality and quantity 
of viable eggs) from age 35 years onwards with it becoming more obvious at age 
40. In comparison, male fertility can persist into old age even though sperm 
counts and semen quality start to deteriorate in men over the age of 45 
(Jungwirth et al. 2012). One of the most common causes of infertility in the male 
is aberrant sperm production. This may result in reduced semen parameters 
such as a low sperm count, reduced sperm movement and abnormal sperm 
structure and function(Jungwirth et al. 2012). 
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The measurement of DNA damage in human spermatozoa has also become a key 
part of the diagnostic work-up of the infertile couple (De Iuliis et al. 2009). DNA 
encodes all the genetic information required for an organism’s development 
throughout life and therefore it is essential that its content is transmitted 
accurately and completely during cell division and reproduction. Damage to 
sperm DNA can manifest as a condensation and protamine-packaging defect, 
incomplete nuclear maturation, DNA breaks or poor DNA integrity (Agarwal et 
al. 2005) giving the DNA a fragmented structure. 
 
The impact of sperm DNA fragmentation on achieving pregnancy either 
naturally or through assisted reproductive technology (ART) treatment has 
been investigated over the past two decades and is recognised as a valuable 
addition to the conventional analysis of standard semen parameters (Aitken et 
al. 2007, Benchaib et al. 2007). Intracytoplasmic sperm injection (ICSI) has 
made the conventional criteria of concentration, motility and morphology for 
assessment of sperm quality irrelevant since there is no longer a natural 
selection process occurring as to which sperm fertilises the female egg. As a 
result the need for new assays for evaluation of sperm integrity has become a 
priority. 
 
Groups using the terminal deoxynucleotidyl transferase (TdT)- mediated 
deoxyuridinetriphosphate (dUTP) nick-end labelling (TUNEL) assay have found 
that high sperm DNA fragmentation reduces the relative ‘risk’ of pregnancy 
after in vitro fertilisation (IVF) and ICSI (Benchaib et al. 2003), increases rates 
of miscarriage (Benchaib et al. 2007, Zini et al. 2008) and decreases clinical 
pregnancy rates after ICSI (Borini et al. 2006) and intrauterine insemination 
(IUI) (Duran et al. 2002). Another concern regarding sperm DNA damage is the 
possible consequence of achieving a pregnancy using a spermatozoon 
possessing such damage (Lewis et al. 2005). If permanent alterations to the 
genetic material occur subsequent generations may also be affected, with 
increases in childhood cancers, diseases and even autism observed (Aitken et al. 
2007, Aitken et al. 2009).
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While the exact mechanisms involved in the etiology of sperm DNA 
fragmentation are yet to be fully elucidated, extensive studies show that 
oxidative stress plays a key role in the aetiology of DNA damage (De Iuliis et al. 
2009). Oxidative stress has been extensively studied in the context of male 
infertility and sperm abnormalities (Agarwal et al. 2003, Tremellen 2008) and is 
widely believed to be the main aetiological factor in sperm DNA damage (De 
Iuliis et al. 2009). Oxidative stress arises as a consequence of excessive 
production of reactive oxygen species (ROS) and impaired antioxidant defence 
mechanisms and the generation of ROS has become a real concern regarding the 
potential toxic effects that high levels can have on sperm quality and function 
(Agarwal et al. 2003). Both systemic inflammation and inflammation local to the 
male reproductive tract are known to generate oxidative stress and affect 
spermatogenesis (Lang et al. 2013), however it is not currently known whether 
sperm DNA damage is most often due to systemic or local oxidative stress. The 
use of mass spectrometry, a technique designed to detect products of oxidative 
stress in body fluids, provides potential for addressing this question (Winnik et 
al. 2008, Vivekanandan-Giri et al. 2011, Lam et al. 2012) and such methods have 
recently been refined by members of our group [De lullis et al. unpublished 
data]. 
 
The 8-hydroxy-2’-deoxyguanosine (8OHdG) base lesion is a useful biomarker 
for the assessment of damage to sperm DNA caused by oxidative stress and the 
levels of 8OHdG have been found to be higher in sperm from infertile men than 
from fertile men (Thomson et al. 2011). Recent studies indicate that an increase 
of 8OHdG in sperm can influence the time taken to achieve a natural pregnancy 
in a healthy population (De Iuliis et al. 2009). Scientists at Fertility First have 
examined the effect of oxidative DNA damage and the presence of the DNA 
adduct 8OHdG on success in ART, demonstrating that the extent of oxidative 
damage to sperm DNA can impact clinical pregnancy rates following IUI 
(Thomson et al. 2011). It has been proposed that threshold values of sperm 
DNA fragmentation and/or oxidative DNA damage can be used to predict the 
chance of a particular sperm population achieving a pregnancy (Simon et al. 
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2010) (Henkel et al. 2004, Boe-Hansen et al. 2006) and members of our group 
were able to determine that a threshold value of 11.5% 8OHdG was a useful 
predictor of IUI success (Thomson et al. 2011). This carries significant 
implications for the clinical management of this male factor infertility. 
 
One of the limitations of the TUNEL and 8OHdG assays however, is that they rely 
on the ability of a protein, terminal transferase and 8OHdG probe to access DNA 
strand breaks. Access can be restricted due to the tightly compacted nature of 
sperm chromatin and this may therefore lead to an underestimation of the 
percentage of DNA fragmentation and oxidative stress levels (Mitchell et al. 
2011). A strategy needs to be adapted to relax the chromatin and allow the 
terminal transferases to access the DNA strand breaks deep within the sperm 
nucleus (De Iuliis et al. 2009). 
 
In light of this, this study has been designed to introduce dithiothreitol (DTT), a 
small molecular mass reducing agent, shown to relax the chromatin structure of 
mammalian spermatozoa in the existing assays for sperm DNA damage as 
described by members of Mitchell et al. (2011). DTT breaks down the 
disulphide bridges between adjacent protamine molecules (Codrington et al. 
2007) therefore decreasing the stability of the chromatin.  Although Mitchell et 
al. (2011) used flow cytometry to assess cell vitality,  as oppose to fluorescent 
microscopy used for this project, no studies to date have determined whether 
the new assays are an improvement to the existing assays in terms of their 
ability to predict success following assisted reproduction.  
 
Furthermore, this study will also assess whether TUNEL assays are profoundly 
influenced by the vitality of the spermatozoa. By isolating highly motile 
spermatozoa via density gradient centrifugation (DGC) prior to analysis 
(Thomson et al. 2009, Thomson et al. 2011) we try to reduce the likelihood of 
inadvertently including non-viable spermatozoa in our analysis of DNA 
damage. However, it is possible that some non-viable spermatozoa will remain 
and until now it has not been possible to simultaneously examine spermatozoa 
for DNA damage and viability. Using a protocol developed by members of our 
group, vitality of the sperm can now be measured using a marker which 
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covalently binds to intracellular amine groups in non-viable cells (Mitchell et 
al. 2011). 
 
When incorporating the two new steps of DTT treatment and LIVE/DEAD 
differential cell staining into the existing TUNEL and 8OHdG assays for sperm 
DNA damage, it would be prudent to compare these updated assay protocols to 
the existing protocols. This will allow us to determine whether the new 
methods are better able to predict a successful outcome following IUI or IVF 
with ICSI cycles. Additionally, using mass spectrometry techniques to analyse 
seminal plasma and blood serum, we will also be able to address whether the 
origins of the sperm DNA damage are local or systemic states of oxidative 
stress which might enable the development of preventative treatment to 
decrease levels of sperm DNA damage in the population. 
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2. Aims and Hypotheses 
 
Hypotheses 
1. The addition of DTT and LIVE/Dead cell staining in the updated TUNEL 
assay protocol for detecting sperm DNA fragmentation and updated 
8OHdG assay protocol for detecting oxidative sperm DNA damage will 
enhance the responsiveness of the assays.  Therefore improving the 
reliability of the assays in predicting a successful outcome following IUI 
and/or IVF with ICSI fertility treatment cycles 
2. The DTT will relax the tightly compacted structure of the sperms 
chromatin and sufficiently allow the assay’s terminal transferase enzyme 
to access the DNA breaks that are deep within the sperm nucleus 
 
3. Levels of either local or systemic oxidative stress will be correlated with 
sperm DNA damage and therefore will provide evidence as to the source 
of this damage 
 
 
Aims 
1. Determine the percentage of sperm exhibiting fragmented DNA and/or 
oxidative DNA damage in the sample prepared and used for either IUI 
or IVF with ICSI cycles using both the existing and updated TUNEL and 
8OHdG assay protocols 
 
2. Compare the percentage sperm DNA damage determined using 
the existing and updated assay protocols 
 
3. Compare the relative abilities of the existing and updated assays to 
predict a successful outcome following either IUI or IVF with ICSI 
 
4. Use mass spectrometry to determine the levels of oxidised nucleic 
acids in seminal plasma and blood serum as indicators of local and 
systemic oxidative stress respectively 
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5. Correlate the levels of local and systemic oxidative stress with the 
levels of sperm DNA damage as determined using each of the existing 
and updated assays 
 
6. Calculate the correlation between local and systemic levels of oxidative 
stress and reproductive outcome 
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3. Expected Research Outcomes 
 
The outcome of this study will be to determine whether the updated TUNEL 
assay protocol for detecting sperm DNA fragmentation and 8OHdG assay 
protocol for detecting oxidative sperm DNA damage will improve the 
sensitivity of these assays and therefore their reliability in predicting a 
successful outcome following IUI and/or IVF with ICSI treatment cycles. This 
will mean that clinicians will be better able to select the most appropriate 
treatment type for fertility patients.  For example, ICSI is recommended for 
males with a high percentage of sperm DNA fragmentation and thereby not 
only improving their chance of a successful outcome but also reducing their 
time and financial costs. 
 
We also expect that levels of local and systemic oxidative stress determined 
using mass spectrometry will provide evidence as to the source of the damage 
to sperm DNA, therefore allowing for the development of targeted therapies to 
reduce the incidence of sperm DNA damage and the chance of fertilisation 
occurring with a spermatozoon of poor genetic integrity. 
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4. Intellectual Context 
 
 
4.1 Introduction 
 
4.1.1 Spermatogenesis 
 
In nature, a successful conception, pregnancy and subsequent birth of a 
healthy infant are the result of an infinitely complex series of events that must 
be overcome in order for the sperm to reach the oocyte. The quality and 
function of the sperm cell are all vital for ensuring an optimal result. 
 
In order to understand male infertility, in terms of causes, diagnosis and 
treatment, it may be helpful to know how the male reproductive system 
works and how sperm are produced. The components of the male 
reproductive tract are displayed in Figure 4.1. 
 
The testicles are the most important organs in male reproduction as they 
make both the sperm and the male hormone testosterone, which also helps 
sperm development. They are made up of many seminiferous tubules and are 
the site of sperm maturation. The insides of the tubules are lined with 
seminiferous epithelium, which consists of two general types of cells; 
spermatogenic cells and sertoli cells [Fig 4.2]. Sertoli cells provide mechanical 
and nutritional support for the spermatogenic cells. Spermatogenic cells are 
the first cells of spermatogenesis. They originate in the 4th week of foetal 
development in the endodermal walls of the yolk sac and migrate to the testis, 
where they differentiate into spermatogonia (Anirudh et al. 2013). 
 
Spermatogonia remain dormant until puberty where they will undergo 
mitosis to increase their number. Some spermatogonia may divide 
continuously however, as stem cells they do not function and their final 
mitosis always results in the formation of primary spermatocytes (Anirudh 
et al. 2013). 
Connected by bridges of cytoplasm, these cells immediately enter the first 
meiotic division, which is extremely prolonged – about 22 days. The 
completion of the first meiotic division results in the formation of secondary 
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spermatocytes, which rapidly enter and complete the second meiotic division 
and subsequently form spermatids (Anirudh et al. 2013) The terminal phase 
of spermatogenesis consists of the differentiation of the newly formed 
spermatids into spermatozoa. This process takes approximately 12 weeks and 
culminates with mature spermatozoon ready for ejaculation. 
 
 
 
 
Figure 4.1 The Male Reproductive Tract 
 
http://www.webmd.com/men/male-reproductive-system 
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Figure 4.2 Spermatogenesis 
 
http://bio1152.nicerweb.com/Locked/media/ch46/spermatogenesis.html 
 
 
4.1.2 Sperm Structure 
 
 
The mature human spermatozoon is about 60 µm long and actively motile. It is 
divided into head, neckpiece, midpiece and tail and can be seen in Figure 4.3. 
The head consists of the acrosome and the nucleus. The acrosome contains 
enzymes important in the process of fertilisation, allowing the sperm to 
penetrate the oocyte. The nucleus occupies most of the available space of the 
sperm head and contains the nuclear DNA of the sperm. The DNA is tightly 
compacted and highly condensed to minimise its volume for transport (Li et al. 
2014). Once the sperm has penetrated the oocyte this high degree of packaging 
allows the DNA to unfold outside the head to allow decondensation 
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to begin. The structural organisation of sperm DNA is likely to be just as vital to 
the proper functioning of the spermatozoa (Ward et al. 1991). 
 
The sperm head is followed by a short neck, which separates it from the 
midpiece of the sperm. The neck consists of just two granules (centrioles) called 
the proximal centriole and the distal centriole (Sathananthan et al. 2001). At 
fertilisation, these centrioles enter the egg and nucleus and help the zygotic 
division by forming the first mitotic spindle. It is known that they are 
responsible for the formation of the microtubules of the sperm tail and 
therefore play a role in sperm motility (Sathananthan et al. 2001). 
 
The midpiece is the first section of the tail and consists of a sheath of ring- 
shaped mitochondria grouped around the axoneme. These mitochondria 
provide energy for the flagellar movement of the sperm. 
 
The sperm tail or flagellum, provides a motile force for the spermatozoon. It is 
based on an arrangement of microtubules within the axoneme which are 
covered by a fibrous sheath for support. Proteins within this fibrous sheath 
appear to be necessary for the process of sperm capacitation and 
hyperactivation prior to fertilisation (Eddy et al. 2003). 
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Figure 4.3 The Human Spermatozoon 
 
 
 
 
http://karimedalla.wordpress.com/2013/03/13/11-4a-spermatogenesis/ 
 
 
 
 
4.1.3 Passage to Ejaculation 
 
 
Spermatozoa leave the testis neither fully motile nor able to recognise or 
fertilise an egg but must traverse a long duct, the epididymis, to acquire these 
abilities. These transformations of the spermatozoa are collectively referred to 
as sperm maturation. Even though sperm have developed the ability for motility 
and to fertilise, they still need to undergo a further maturation step in the 
female reproductive tract before they achieve their full fertilisation potential. In 
addition to the numerous changes that the maturing spermatozoa undergo 
during their transit along the epididymal duct, the epididymis will also protect 
spermatozoa from the external environment. 
 
Once the spermatozoa have detached from the sertoli cells of the seminiferous 
tubules, they enter the rete testis and then on through the efferent ductules to 
1.2.3 Passage to Ejaculation 
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the first part of the epididymis, known as the head or caput epididymis [Figure 
4.4]. 
 
The head of the epididymis is the site of large reabsorption of water, which 
serves to increase the concentration of sperm by up to 100 fold. Although water 
is still absorbed as the sperm move through the remainder of the epididymis, 
the head is where the majority of the water is removed. 
 
The spermatozoa travel from the head through the body (corpus) and the tail 
(cauda). The wall of the epididymis which can be up to six meters in length 
(Bedford 1994), secretes a complex array of substances at various 
concentrations and locations serving to create different environments through 
which the spermatozoa travel during stages of their maturation. A number of 
proteins synthesised and secreted by the epididymal epithelium adhere to and 
interact with spermatozoa (Srivastava et al. 1991). These proteins have been 
implicated in a number of different processes related to sperm motility (Turner 
et al. 1982), modification of the sperm surface during transit, sperm maturation 
and fertilising ability and the protection of spermatozoa (Ghyselinck et al. 
1993). 
 
 
Once through the epididymal duct, the spermatozoa are then stored in the tail 
until ejaculation. The tail of the epididymis is positioned furthest from the body 
to maintain a cooler temperature whilst being stored. Long periods of time 
spent in storage however, can be detrimental to the sperm, reducing the 
motility of the ejaculate (Bedford 1994) and exposing the spermatozoa to 
reactive oxygen species (ROS); therefore capable of causing oxidative stress and 
DNA damage (Baker et al. 2005). 
 
At the time of ejaculation the spermatozoa leave the cauda and travel up the vas 
deferens to the posterior urethra. At this point, sperm are travelling in 
epididymal fluid, which constitutes approximately 5% of the final semen 
volume. During the final process of ejaculation, the spermatozoa are propelled 
down and finally exit the urethra. Following the sperm and epididymal fluid are 
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two thirds; prostatic and seminal vesicle fluids. Prostatic fluid constitutes 10- 
30% of the final semen volume and is produced in the prostate gland. It contains 
different enzymes involved in coagulation and liquefaction of semen following 
ejaculation. It is delivered directly to the urethra during ejaculation. 
 
The seminal fluid is the largest component of semen, contributing to 40-60% of 
the final volume. The seminal fluid contains fructose as the major component, 
serving as an energy source for the spermatozoa supporting motility, 
prostaglandins, ascorbic acid (antioxidant), inorganic phosphate, potassium and 
a coagulation-inducing protein. The components of this fluid cause semen to 
have a slightly alkaline pH; consequently the fluid is very important for the 
function of the spermatozoa. Semen lacking seminal vesicle secretions 
possesses sperm that are predominately immotile. 
 
The epididymal, prostatic and seminal vesicle components of seminal plasma 
travel closely but separately down the urethra and are led by another secretion 
that is produced by the bulbourethral and urethral glands. This fluid serves to 
lubricate the urethral lining to facilitate the smooth passage of semen during the 
final process of ejaculation. It consists of immunoglobulins (specifically IgG) and 
mucoproteins. These immunoglobulins can be directed against the spermatozoa 
and can be the reason for infertility in some men. 
 
Upon arrival in the vagina, all components combine and interact. The different 
proteins and enzymes present in each fluid cause the semen to coagulate and 
then liquefy, which can take 2 to 60 minutes following ejaculation. 
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Figure 4.4 The Structure of the Testis and Epididymis 
 
http://medicine.academic.ru/2800/Epididymis 
 
 
4.1.4 Transport Through the Female Reproductive Tract and Capacitation 
 
 
To ensure that sperm with normal semen parameters, in particular, normal 
morphology and vigorous motility, will be the ones to penetrate the egg, the 
female reproductive tract is regulated to maximise the sperm’s chance of 
fertilisation. 
 
When the spermatozoa are deposited into the anterior vagina, they quickly 
contact cervical mucus and enter the cervix to avoid vaginal acid and immune 
responses. The seminal fluid helps act as a buffer against the harsh acidic 
environment of the vagina and also contains immunosuppressive properties to 
protect the spermatozoa from an immune attack. (Harris et al. 2006) 
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The normal human ejaculate contains many tens to hundreds of millions of 
motile spermatozoa; however this incredible output far exceeds the number of 
sperm required for successful fertilisation - one. The reason for this is that 
despite the deposition of this excessive number of motile cells, not all of these, 
and in fact very few, will make it to journey’s end. Many cells will not pass into 
the cervical mucus. Of those that do penetrate the mucus, passage through the 
cervix and into the uterus will be possible only for sperm with vigorous 
progressive motility, morphological normality and a plasma membrane that is 
functioning appropriately. The uterus then acts to further the selection process; 
for example, motility may diminish or fail for some sperm; others may undergo 
a premature and degenerative acrosome reaction rendering them inviable. 
Other sperm may succumb to the deleterious effects of leukocyte-produced 
reactive oxygen molecules (Aitken et al. 2006). At most, perhaps 10 to 20 
spermatozoa might reach the zona surface of the oocyte and the race to the 
finish will be governed by the normality of the oocyte and spermatozoon, 
effective ligand–receptor interactions, functionally active signal transduction 
cascade pathways and—a bit of luck (Ho et al. 2001). 
 
Sperm can survive for weeks in the male reproductive tract but once ejaculated 
into the female reproductive tract they only survive about 24-72 hours. Sperm 
undergo morphological, physiological and biochemical changes during 
transport through the female reproductive tract. These changes need to occur 
before the sperm are capable of penetrating the oocyte. 
 
The capacity of spermatozoa to fertilise an oocyte is enhanced if they spend 
some time in the female reproductive tract. This is called capacitation and 
makes the sperm able to adhere better to the oocyte. The seminal plasma 
contains factors that do not allow the spermatozoa to penetrate the oocyte; 
corona-penetrating inhibitor and acrosin inhibitor, which are subsequently 
removed in the female reproductive tract. A feature of capacitation is the change 
in the movement displayed by the spermatozoa referred to as hyperactivation, 
where the tail of the spermatozoon becomes increasingly curved and movement 
becomes hyperactive.  The type of motility characteristic of hyperactivation, as 
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well as changes in the membrane that occur during capacitation, are what 
assists sperm in reaching the oocyte (Suarez et al. 2006). 
 
Capacitation is characterised as a complex of structural and functional changes 
occurring in spermatozoa and is considered to be complete when they are able 
to respond to zona pellucida ligands by undergoing the acrosome reaction (De 
Jonge 2005). Therefore capacitation is an essential stage of sperm development 
leading to fertilisation. 
 
4.2 Male factor infertility 
 
4.2.1 Reduced Semen Parameters 
 
Male infertility is indeed becoming an epidemic problem affecting almost 5% of 
the male population (Jungwirth et al. 2012). In order to assess male factor 
infertility a semen analysis is performed to determine the number, shape and 
movement of the spermatozoa in a sample. The semen analysis involves 
examining the spermatozoa and the seminal fluid, semen being a mixture of 
spermatozoa suspended in a secretion from the testis and epididymis that is 
combined with secretions from the prostate, seminal vesicles and bulbourethral 
glands (Durairajanayagam et al. 2015). From this analysis, in conjunction with 
other results from the partner, clinicians can select which form of treatment 
may be most appropriate. 
 
Reduced male fertility can be the result of congenital and acquired urogenital 
abnormalities, infections of the male accessory glands, increased scrotal 
temperature (varicocele), endocrine disturbances, genetic abnormalities and 
immunological factors (Dohle et al. 2005). In 40–60% of cases the only 
abnormality is the semen analysis and there is no relevant history or 
abnormality on physical examination and endocrine laboratory testing. This is 
referred to as idiopathic male infertility (Dohle et al. 2005). 
 
Table 4.1 Lists the World Health Organisation (WHO) criteria for a normal 
semen analysis. Reduced semen parameters reveal a decreased number of 
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spermatozoa (oligozoospermia), decreased motility (asthenozoospermia) and 
many abnormal forms of morphology (teratozoospermia). A summary of the 
nomenclature for semen constituents is described in Table 4.2. 
 
Despite a low sperm count, many men with high–quality spermatozoa 
(viable and highly motile) may still be fertile. 
 
Table 4.1 WHO 2010 criteria for a normal semen analysis 
 
Normal semen criteria WHO 
2010 
Lower reference limit 
Volume ≥ 1.5 ml 
Total No. of spermatozoa ≥ 39 x 106 
Concentration ≥ 15 x 106/mL 
Total Motility (PR & NP) ≥ 40% 
Progressive Motility (PR) ≥ 32% 
Morphological normal sperm ≥ 4% 
World Health Organisation (Cooper et al. 2010). 
PR = Progressive. NP = Non-progressive 
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Table 4.2 Nomenclature for semen variables 
 
Normozoospermia Normal ejaculate (as defined by 
reference values in Table 4.1) 
Oligozoospermia Sperm concentration, < 15 
million/ml 
Asthenozoospermia <40% spermatozoa with forward 
progression or, <32% spermatozoa 
with rapid progression 
Oligoasthenoteratozoospermia Disturbance of all three variables 
Teratozoospermia < 4% spermatozoa with normal 
morphology 
Azoospermia No spermatozoa in the ejaculate 
Aspermia No ejaculate 
World Health Organisation (Cooper et al. 2010) 
 
 
Although the diagnosis of male infertility is quite often based only on semen 
analysis, for many clinics, unless the patient is diagnosed with azoospermia 
(absence of sperm in the ejaculate), the semen analysis remains no more than a 
rough guide for differentiating the fertile from the sub-fertile patients. Semen 
analysis is mainly only providing information poorly predictive of the male 
fertility status as it mainly gives information regarding the status of the male 
genital tract and thus only indirectly indicates the male fertility potential. 
 
In today’s modern world assisted reproduction technology (ART) is becoming 
more diverse in the treatments that are offered to patients, and therefore we are 
risking the removal of many of the natural selection barriers that are put in place 
to ensure that the best spermatozoa are used for fertilisation. Therefore emphasis 
needs to be on a semen analysis and develop to a point where clinicians can 
provide patients not only with some idea of the prognosis in terms of natural 
conception, but also whether assisted reproduction treatment will have a 
successful outcome both in terms of fertilisation and in creating a healthy fetus. 
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4.2.2 Sperm DNA Damage 
 
 
Although previous discussions have shown that the conventional semen analysis, 
when performed properly can provide useful clinical information, the 
information is clearly limited in terms of its’ ability to predict outcome. The 
determination of sperm number, ability to swim and estimates of shape and size 
cannot determine how well the sperm is able to bind to the oocyte, initiate 
fertilisation or relate to the development of the embryo. These questions require 
a more detailed investigation of sperm structure and function. Sperm DNA 
damage testing has been proposed for a number of years as a useful 
supplementary investigation for the ‘subfertile’ man (Aitken & De Iuliis, 2007; 
Evenson et al., 2007; Lewis, 2007; Giwercman et al., 2010; Barratt et al., 
2010) and has been suggested by some to be more robust than conventional 
semen parameters as a predictor of outcome (Lewis, 2007;Castilla et al., 
2010) (Lewis et al. 2005). 
 
The evaluation of semen parameters is still the gold standard in diagnosing male 
infertility, however molecular testing is needed to provide a more robust 
prognostic tool in ART. Through many quantitative studies, sperm DNA damage 
has been reported to be a more robust biomarker. Sperm DNA damage has 
associations with all ART outcomes, but specifically with fertilisation (Simon et al. 
2011). 
 
DNA damage in the male germ line has been associated with poor semen quality, 
low fertilisation rates, impaired preimplantation development, increased 
abortion and an elevated incidence of disease in the offspring, including 
childhood cancer (Lewis et al. 2005). The causes of this DNA damage are still 
uncertain but the major candidates are oxidative stress and abnormal apoptosis 
(Long et al. 2007). Positive results have been reported for antioxidant therapy 
both in vivo and in vitro. However, resolving the causes of DNA damage in the 
male germ line will be essential if we are to prevent the generation of genetically 
damaged human embryos, particularly in the context of assisted conception 
therapy. 
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4.2.2.1 Introduction to DNA 
 
 
There are three different types of biological molecules used by all modern life on 
Earth that each serve critical functions in the cell; Proteins which are the 
workhorse of the cell and carry out diverse catalytic and structural roles, while 
the nucleic acids, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), carry 
the genetic information that can be inherited from one generation to the next . 
 
DNA is considered the ‘blueprint’ of the cell as it carries all of the genetic 
information required for an organism’s development throughout life. Nearly 
every cell in a person’s body has the same DNA. Most DNA is located in the cell 
nucleus, where it is called nuclear DNA, but a small amount of DNA can also be 
found in the mitochondria, where it is called mitochondrial DNA or mtDNA 
(Hazkani-Covo et al. 2010). 
 
The information in DNA is stored as a code made up of four chemical bases: 
adenine (A), guanine (G), cytosine (C), and thymine (T) (Sinden 2012).  Outlined 
in Fig 4.5, DNA bases pair up with each other, A with T and C with G, to form units 
called base pairs. Each base is also attached to a sugar molecule and a phosphate 
molecule. Together, a base, sugar, and phosphate are called a nucleotide (Egli et 
al. 2013). Nucleotides are arranged in two long strands that form a spiral called a 
double helix.  The structure of the double helix is somewhat like a ladder, with 
the base pairs forming the ladder’s rungs and the sugar and phosphate molecules 
forming the vertical sidepieces of the ladder (Sinden 2012). 
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Fig 4.5 DNA Structure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Image from http://study.com/cimages/multimages/16/DNA_simple2.svg.png 
 
 
A critical property of DNA is that it can make copies and replicate itself. In the 
double helix, each strand of DNA can serve as a template for duplicating the 
sequence of bases. This is important when cells divide because each new cell 
needs to have an exact replica of the DNA present in the original cell (Alberts et 
al. 2013). Typically RNA is found in a single-stranded form, therefore the lack of a 
paired strand allows RNA to fold into complex, three-dimensional structures. 
Similar to DNA, RNA folding is mediated by the same type of base-base 
interactions, except that bonds are formed within a single strand in the case of 
RNA, rather than between two strands of DNA (Leontis et al. 2001). 
 
RNA plays a central role in the pathway from DNA to proteins. RNA is the ‘DNA 
photocopy’ of the cell. When the cell needs to produce a certain protein, it 
activates the protein’s gene–the portion of DNA that codes for that protein–and 
produces multiple copies of that piece of DNA in the form of messenger RNA, or 
mRNA (Alberts et al. 2013). These copies are then used to translate the genetic 
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code into protein through the action of the cell’s protein manufacturing 
machinery, the ribosomes (Alberts et al. 2013). Thus, RNA plays a crucial role in 
regulating how much protein is made at one time from one given gene. 
 
The structure of RNA nucleotides is very similar to that of DNA nucleotides, 
except the ribose sugar backbone in RNA has a hydroxyl (-OH) group whereas the 
DNA does not (Sinden 2012). Also, DNA uses the base thymine (T) in place of 
uracil (U). Despite great structural similarities, DNA and RNA play very different 
roles from one another in modern cells. 
 
Human DNA consists of about 3 billion bases (Nussbaum et al. 2007) and more 
than 99 percent of those bases are the same in all people. The order, or sequence, 
of these bases determines the information available for building and maintaining 
an organism. The bases are distributed over 23 pairs of chromosomes. In almost 
every cell in the human body there are 22 pairs of autosomal homologous 
chromosomes and two sex chromosomes. These cells are diploid cells. Each 
chromosome consists of a single linear DNA molecule and is enclosed within the 
nucleus of non-dividing cells. Due to the size of the nucleus, the DNA must be 
tightly packed and condensed in order to fit. This is achieved with an elaborate 
packing procedure whereby the DNA attaches to proteins called histones. The 
linear DNA is wrapped around these proteins to form nucleosomes and these 
nucleosomes are in turn wrapped around each other to form a tightly packed 
condensed fiber known as chromatin. During cell division, the highly condensed 
chromatin must unravel in order to allow access to the machinery involved in this 
process. 
 
4.2.2.2 The DNA of Spermatozoa 
 
 
The spermatozoon is a gamete and therefore haploid cell containing a single set 
of 23 chromosomes including one sex chromosome (Wang et al. 2012). During 
spermatogenesis, spermatocytes divide meiotically to yield four haploid 
spermatids. Genetic diversity is achieved through random separation of the 
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homologous chromosomes and exchange of genetic material known as crossing- 
over. 
 
The formation of mature spermatozoa is a unique process involving a series of 
meiosis and mitosis, changes in cytoplasmic architecture, replacement of somatic 
cell-like histones with transition proteins and the final addition of protamines, 
leading to a highly packaged chromatin (Oliveira et al. 2015). The chromatin 
contained in the nuclei of mature mammalian spermatozoa is an extremely 
compact and stable structure. Sperm DNA must be organised in a specific 
manner, which differs substantially from that of somatic cells, to achieve this 
unique condensed state (Poccia 1986, Ward et al. 1991). This DNA organisation 
not only permits transfer of the very tightly packaged genetic information to the 
egg, but also ensures that the DNA is delivered in such a physical and chemical 
form that the developing embryo can access the genetic information. 
 
4.2.2.3 Sperm Chromatin Structure 
 
 
Sperm chromatin differs from somatic cell chromatin in structure and 
composition. During spermatogenesis the majority of histones are replaced with 
small, highly basic protamines that are half the size of histones (Fuentes- 
Mascorro 2000) and the DNA is organised into unique supercoiled doughnuts, 
called toroids (Ward et al. 1991). During transit though the epididymis, the 
protamines crosslink by forming disulphide bonds; this type of packaging 
enables the sperm DNA to fit into the small area of the head and is at least six 
times more condensed than the DNA of somatic cells. (Fuentes-Mascorro 2000). 
This highly cross-linked structure affords a measure of protection to sperm DNA 
and to some extent compensates these cells for their impaired DNA repair 
capacity. 
 
However, unlike other mammals in which sperm DNA is associated with only one 
protamine (P1), human spermatozoa have two types of protamine (P1 and P2). 
P2 has fewer thiol groups for disulphide bonding and this makes human sperm 
chromatin less stable (Jager 1990). 
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The sperm's entire haploid genome is organised into DNA loop domains that have 
an average length of 27 kilobytes. These loops are attached at their bases to a 
structural element within the sperm nucleus known as the nuclear matrix. When 
the human sperm undergoes decondensation, the DNA remains anchored to the 
base of the tail. This fact suggests the presence of a nuclear annulus-like structure 
in human sperm (Wang et al. 2012). This DNA organisation not only permits the 
very tightly packaged genetic information to be transferred to the egg, but also 
ensures that the DNA is delivered in a physical and chemical form that allows the 
developing embryo to access the genetic information (Sakkas et al. 1999). 
 
Compaction of sperm chromatin makes the cells more resistant to exogenous 
assault. This resilience is reflected by the high levels of irradiation required to 
damage sperm DNA compared with somatic cells (McKelvey-Martin et al. 1997) 
and by the relative resistance of the sperm nuclear genome to damage when 
treated with high concentrations of hydrogen peroxide (Sawyer et al. 2001, 
Sawyer et al. 2003). 
 
Even in fertile men, DNA damage in sperm appears to be more common than in 
somatic cells (McKelvey-Martin et al. 1997). Furthermore, in infertile patients, 
the levels of DNA damage seen in normal spermatozoa are elevated further still 
(Irvine et al. 2000). Interestingly, several studies have shown that sperm from 
infertile men not only exhibit more basal DNA damage but are also more 
susceptible to damage from both hydrogen peroxide and X-irradiation 
(McKelvey-Martin et al. 1997, Hughes et al. 1998). 
 
4.2.2.4 Origins of Sperm DNA Damage 
 
 
The sources of sperm DNA damage in the male germ line have not yet been fully 
elucidated. Damage may occur at testicular, epididymal or post-ejaculatory levels 
of the male reproductive tract. Defects in sperm DNA can manifest as 
condensation and protamine-packaging defects, incomplete nuclear maturation, 
DNA breaks, poor DNA integrity and/or chromosomal aneuploidies (Agarwal et 
al. 2005). This can disturb the highly refined biochemical events that 
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occur during spermatogenesis, ultimately leading to an abnormal chromatin 
structure that is incompatible with fertility (Agarwal et al. 2003). 
 
And although the exact mechanism(s) by which chromatin abnormalities/DNA 
damage arise in human spermatozoa is not precisely understood, three main 
theories have been proposed; oxidative stress, sperm chromatin packaging and 
apoptosis. 
 
4.2.2.4.1  Oxidative Stress 
 
 
Of the many causes of male infertility, oxidative stress has been identified as one 
factor that compromises fertility status and as a result, has been studied 
extensively in recent years. Like any other aerobic cell, spermatozoa are 
constantly facing the ‘oxygen-paradox’ – The theory that higher eukaryotic 
aerobic organisms cannot exist without oxygen, yet oxygen is inherently 
dangerous to their existence (Sies 1994). Oxygen is required to sustain life, 
similarly to physiological levels of ROS that are necessary to maintain the 
normal functioning of cells. However, breakdown products of oxygen such as 
ROS can be detrimental to cell function and survival (Makker et al. 2009). 
 
In recent years concern has been expressed about the generation of an 
increased presence of ROS in the male reproductive tract. Examples of ROS 
include the hydroxyl ion, superoxide, hydrogen peroxide, peroxyl radical and 
hypochlorite ion. These are common forms of ROS that have been considered 
injurious to sperm survival and function when present in high levels (Saleh et al. 
2002). The presence of high ROS levels has been reported in semen of between 
25 and 40% of infertile men (Pasqualotto et al. 2000). 
 
The characteristic tight packaging of the DNA and the antioxidants present in 
seminal plasma are two factors that help protect the sperm DNA from oxidative 
attack. However, oxidative stress is a consequence of an imbalance between 
production of ROS and the body’s antioxidant defense mechanisms. Oxidative 
stress also has been implicated in the pathogenesis of many other human 
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disease such as atherosclerosis, cancer, diabetes, liver damage, rheumatoid 
arthritis, cataracts, AIDS, inflammatory bowel disease, central nervous system 
disorders, Parkinson’s disease, motor neuron disease and conditions associated 
with premature birth (Agarwal et al. 2005). 
 
Until recently ROS were considered exclusively toxic to human spermatozoa. 
However, substantial evidence suggests that small amounts of ROS are 
necessary for spermatozoa to be capable of fertilisation (Aitken 1997, Aitken 
1999) Low levels of ROS are not only essential for fertilisation, but are also 
necessary for acrosome reaction, hyperactivation, motility and capacitation 
(Agarwal et al. 2004). Capacitation is a process that prepares the spermatozoa 
for interaction with the oocyte occurring in the female genital tract. It is during 
this process that levels of intracellular calcium, ROS and tyrosine kinase all 
increase, leading to an increase in cyclic adenosine monophosphate (cAMP). 
The increase in cAMP results in the hyperactivation of spermatozoa, allowing 
the spermatozoa to become highly motile (Baker et al. 
2009). It is only when the spermatozoa are hyperactivated that they undergo a 
physiological acrosome reaction, thereby having the ability to fertilise (de 
Lamirande et al. 2008). Reactive oxygen species also have been implicated in 
sperm oocyte interaction (Agarwal et al. 2008). Lipid peroxidation caused by 
low levels of ROS leads to modification of the plasma membrane and therefore 
facilitates sperm-oocyte adhesion (Kothari et al. 2010). 
 
Sources of ROS include a collection of radical (hydroxyl ion, superoxide, nitric 
oxide, peroxyl etc) and non-radical (ozone, singlet oxygen, lipid peroxide, 
hydrogen peroxide) oxygen derivatives (Agarwal et al. 2005). These molecules 
give rise to free radicals when they participate in a cascade of reactions, 
damaging organic substrates. Since human semen is known to contain different 
types of cells, such as immature and mature spermatozoa, round cells from 
different stages of spermatogenesis, leukocytes and epithelial cells, nearly every 
human ejaculate is considered to be contaminated with potential sources of ROS 
(Kothari et al. 2010). Of these different cell types, spermatozoa and leukocytes 
have been shown to be the two main sources of ROS (Garrido et al. 2004). 
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Other major sources of ROS include cytoplasmic droplets, or excess residual 
cytoplasm. Gomez et al (1996) showed that cytoplasmic droplets, a result of 
defective spermatogenesis are a major source of ROS and may explain the 
missing link between poor sperm quality and increased ROS generation. 
Immature, or spermatozoa with abnormal morphology may also be responsible 
for the production of excessive amounts of ROS in human ejaculates (Agarwal et 
al. 2003). Although the mechanism by which this occurs is not known, it is 
proposed that it may be due to the retention of excess residual cytoplasm 
following spermatogenesis (Gomez et al. 1996). This excess cytoplasm increases 
the surface area of the plasma membrane, acting as an additional source of 
unsaturated fatty acids, which have been shown to increase ROS. An increase in 
surface area of the plasma membrane also means an increase in the 
concentration of oxidase, hence contributing to an increase in the levels of ROS 
(Aitken et al. 2007). 
 
Essentially all cellular components such as, lipids, proteins, DNA and sugars are 
potential ROS targets. The extent of damage induced by oxidative stress 
depends on the nature and amount of ROS, the duration of exposure and on the 
extracellular factors including temperature, oxygen levels and the contents of 
the surrounding environment – i.e. the presence of ions, protein and ROS 
scavengers (Sikka 2001). 
 
The macromolecules most susceptible to a state of oxidative stress are lipids. 
Lipids, which are normally present in the sperm membrane in the form of 
polyunsaturated fatty acids, undergo peroxidation when attacked by ROS. One 
of the byproducts of lipid peroxidation is malondialdehyde, which has been 
used in various biochemical assays to monitor the degree of peroxidative 
damage sustained by spermatozoa. The results of such an assay have shown a 
positive correlation when examining the relationship between impaired sperm 
function, in terms of motility, and the capacity for sperm-oocyte fusion (Makker 
et al. 2009). 
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When DNA is damaged by oxidative stress it causes modification of all bases, 
deletions, frame shifts, DNA cross-links and chromosomal rearrangements 
(Duru et al. 2000). Single- and double-stranded DNA breaks are also associated 
with oxidative stress, causing many types of gene mutations, such as point 
mutations and polymorphism, resulting in decreased semen quality 
(Spiropoulos et al. 2002, Sharma et al. 2004). A common byproduct of DNA 
oxidation, 8-hydroxy-2-deoxyguanosine (8OHdG), is a key biomarker of 
oxidative DNA damage (Valavanidis et al. 2009). The spermatozoon can repair 
itself when the extent of DNA damage is small, and the oocyte is also capable of 
repairing the damaged DNA of spermatozoa to some extent. It is when the 
damage is extensive that detrimental effects can occur such as embryo 
fragmentation leading to apoptosis, decreased fertilisation rates, poor embryo 
cleavage and quality (Sakkas 1999). DNA damage in the Y chromosome also can 
cause gene deletion in the Y chromosome of the offspring, leading to infertility 
(Bellver et al. 2010). 
 
Environmental and lifestyle exposures are also related to oxidative stress 
including exposure to polycyclic aromatic hydrocarbons, transition metals, 
anesthetic gases, cigarette smoke, solvents, pesticides and radiation (Fraga et al. 
1996, Aitken et al. 2003). Spermatozoa have also been found to contain 
oxidoreductase enzymes that are capable of generating ROS through the 
activation of xenobiotics (Lewis et al. 2005); a potentially dangerous or toxic 
chemical that the body does not produce or synthesise itself, for example 
antibiotics. 
 
Due to the lack of cytoplasmic enzymes, spermatozoa are unable to repair 
oxidative damage. However, studies have shown that antioxidants play an 
important role in protecting spermatozoa from ROS producing abnormal 
spermatozoa, scavenge ROS produced by leukocytes, prevent DNA 
fragmentation, improve semen quality in smokers, reduce cryodamage to 
spermatozoa, block premature sperm maturation and stimulate spermatozoa 
and improve ART outcome (Kefer et al. 2009). The role of antioxidants has been 
shown to increase sperm motility. A randomised in vivo 
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double-blind controlled trial has shown that vitamin E administered orally 
results in a decrease in malondialdehyde (a marker for lipid peroxidation) 
concentration in spermatozoa and improved sperm motility (Suleiman et al. 
1996). Another study revealed that incubating sperm with the antioxidant D- 
penicillamine also significantly increased sperm motility (Wroblewski et al. 
2003). 
 
The results from in vitro trials also showed potential advantages of antioxidants. 
One study showed that supplementing the sperm preparation media with a 
combination of vitamin C and E correlated with a decreased ROS production by 
the sperm (Donnelly et al. 1999). In the clinical ART setting, various 
antioxidants including vitamin E, vitamin C cysteine and taurine and 
hypotaurine added to the culture medium can improve the developmental 
ability of the embryos by reducing the effects of ROS (Esfandiari et al. 2005). 
 
Antioxidants have also been shown to decrease the DNA fragmentation caused 
by oxidative stress. Daily oral consumption of 1g vitamins C and E for two 
months is reported to decrease the number of TUNEL positive spermatozoa 
from 22.1% to 9.1% (Greco et al. 2005), also showing a significant improvement 
of clinical pregnancy and implantation rates after antioxidant treatment 
compared with the pre-treatment outcomes of ICSI (Greco et al. 2005). 
 
Pioneering work in the field of ROS has developed phenomenal knowledge of 
male reproduction, sperm function and development of diagnostic tools and 
treatment for male infertility. Although oxidative stress is only one cause of 
male infertility, it highlights the mechanism of production and pathophysiology 
of ROS in relation to the male reproductive system and emphasises the benefits 
of incorporating antioxidants in clinical and experimental settings. 
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4.2.2.4.2  Advancing Paternal Age 
 
 
Growing evidence suggests that male reproductive function declines with age 
and that ageing is associated with decreased sperm quality (Paul et al. 2013). 
The age of male partners correlates with decreased germ cell number and 
hence, reduced testicular weight (Wright et al. 1993), decreased sperm motility 
and abnormal morphology (Molina et al. 2010) as well as reduced pregnancy 
rates and increased time to pregnancy (de La Rochebrochard et al. 2006). There 
also seems to be an increased incidence of structural chromosomal aberrations 
and complex multigene diseases in the children of older men with studies 
reporting increased incidences of autism (Hultman et al. 2011) and 
schizophrenia (Sipos et al. 2004) in the offspring of fathers aged greater than 50 
years. 
 
Several studies have demonstrated that sperm DNA fragmentation is positively 
correlated with advanced paternal age. Moskovtsev et al ( 2006) reported that 
DNA fragmentation was significantly higher in men who were more than 45 
years old, with the sperm percentage DNA fragmentation index (DFI) doubling 
in those men 45 years and older compared to those less than 30 years old. Their 
study consisted of men presenting for fertility investigation and included both 
fertile and infertile men. Further studies reported that sperm DNA damage 
almost doubled from 25 to 55 years of age, in a study involving 215 first 
pregnancy planners with unknown fertility capability (Spanò et al. 2000). In 
support of these findings Singh et al (Singh et al. 2003). reported that the 
percentage of sperm with highly damaged DNA was significantly higher in men 
aged 36-57 years than in those aged 20-35 years. They also noted an age-related 
decrease in sperm apoptosis and proposed that the high sperm DNA damage 
with increasing age could be the result of a less efficient sperm cell selection 
process with age (Erenpreiss et al. 2008). However, an important weakness of 
most studies relating to sperm DNA damage and paternal age is that the patient 
populations are highly selected; i.e. infertile men. As a result, it is unclear 
whether the younger and older cohorts have comparable severity of infertility 
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with similar conventional semen parameters, which would allow for fair 
comparison of the two groups. 
 
Advanced paternal age has also been associated with reduced fertility and poor 
semen parameters, in particular, reduced semen volume, motility and 
morphology (Eskenazi et al. 2003, Kühnert et al. 2004). Therefore, this raises 
questions as to whether the relationship between paternal age and sperm DNA 
damage is independent of the relationship between paternal age and 
conventional semen parameters or the severity of infertility. Das et al (2013) 
found that the sperm percentage DFI was significantly higher in 
normozoospermic men with advanced age (≥40) compared to younger men 
(<40). Das et al (2013) also showed that the prevalence of high levels of sperm 
DNA damage in normozoospermic men was significantly higher in the older 
compared to younger men (17% vs. 3%, respectively). These findings suggest 
that the relationship between paternal age and sperm DNA damage does not 
parallel the relationship between paternal age and conventional semen 
parameters. Therefore the conventional semen analysis alone may fail to 
uncover defective spermatozoa in older men (Das et al. 2013). 
 
As a consequence of an age-associated increase in reproductive tract oxidative 
stress and/or testicular germ cell apoptosis, older men may produce more 
sperm with DNA damage (Barnes et al. 1998) (Barroso et al. 2000) (Print et al. 
2000). Oxidative stress within the testis and reproductive tract can damage 
sperm DNA, as mentioned previously, as well as the sperm mitochondrial and 
nuclear membranes (Aitken et al. 2003). Although germ cell apoptosis is a 
normal event, the process may be less effective in older men and as a result, this 
may release more DNA-damaged sperm (Print et al. 2000). However, while 
apoptosis has been identified in the testes of elderly men, there have been no 
comparisons on the rates of germ cell apoptosis among men of different ages 
(Das et al. 2013). 
 
The influence of sperm DNA damage on the health of the child is unknown 
because of the lack of human clinical studies on the subject. In experimental 
34  
studies on mice, sperm DNA damage has been associated with chromosomal 
abnormalities, developmental loss, reduced longevity and birth defects (Haines 
et al. 1998, Fernández-Gonzalez et al. 2008). In humans, advanced paternal age 
is associated with rare autosomal dominant diseases such as achondroplasia 
and Apert’s syndrome, both due to mutations, however whether this be due to 
the integrity of the sperm DNA, it is yet to be verified (Kühnert et al. 2004, Kong 
et al. 2012) 
 
4.2.2.4.3 Lifestyle factors 
 
 
There may not always be a specific male disorder associated with male 
infertility and for this reason environmental factors, such as estrogenic 
pollutants, obesity and lifestyle factors such as psychological stress, smoking 
and alcohol intake should be taken into account. 
 
There is some evidence that workplace exposure to toxic substances such as 
certain pesticides, radiation, heat and metals are known to affect and reduce 
semen quality in different ways (Jensen et al. 2006). It is possible that men 
suffering from infertility problems may be doing so as a result of their 
occupations, where exposure to these substances may be a contributory factor, 
if not a direct cause, of their infertility. Studies specifically investigating DNA 
integrity have shown that exposure to specific compounds can negatively affect 
sperm DNA integrity (Spano et al. 2005). However another study showed no 
relationship between occupation and DNA fragmentation when comparing 
patient demographics (Wyrobek et al. 2006). Additional, controlled studies 
need to be conducted to ascertain the effects of occupational toxins on male 
infertility. 
 
Cigarette smoking and alcohol consumption have been proposed to impact on 
male infertility and consequently, reproductive outcomes. Nicotine, the main 
component of cigarettes, has been found to have deleterious effect on sperm 
parameters (Hassan et al. 2009). Chronic exposure of spermatozoa to such toxic 
components as nicotine have been associated with sperm cell death, a situation 
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that is derived after the damage of sperm DNA (Calogero et al. 2009). Multiple 
studies have proved that smoking induces alterations in semen including an 
increase in ROS and decline in antioxidant molecules (Frey et al. 2008, Soares et 
al. 2008). It has been reported that smoking has a negative effect on semen 
parameters including semen volume, sperm concentration, motility and DNA 
fragmentation (Tawadrous et al. 2011, Taha et al. 2012). However, other studies 
failed to find any impact of cigarette smoking on sperm parameters (Ozgur et al. 
2005, de Jong et al. 2014). 
 
Several studies focused on the association between alcohol consumption and 
male fertility. Alcohol intake has been related to reduced semen parameters 
including semen volume, sperm count, motility and morphology (Muthusami et 
al. 2005). Excessive consumption has been implicated in the alteration of serum 
hormonal levels, which in turn result in the reduction of seminal plasma fluid 
(Kucheria et al. 1985), underlying a possible inhibitory role of alcohol on 
gonadotrophin secretion (Salonen et al. 1992). 
 
Stress is another lifestyle factor that is one of the most important health and 
social problems. It can play a detrimental role in fertility. Psychological distress 
has often been suggested as a cause of unexplained infertility (Sheiner et al. 
2002). A meta-analysis suggested that semen quality was adversely affected by 
job, life events or social related stress (Li et al. 2011). Smoking, alcohol 
consumption and psychological stress are found to be significant risk factors for 
semen quality in both infertile and healthy men (Li et al. 2011). However case- 
control or further cohort studies are needed to further identify the role of 
additional socio-psycho behavioral factors in male semen quality. 
 
Studies also show a significant relationship between sperm DNA 
fragmentation and period of sexual abstinence (Spano et al. 1998, Pons et al. 
2013). These studies suggest that DNA fragmentation depends on the time 
that the mature gamete stays in the epididymis with the longer the stay, the 
greater the probability of sperm deterioration. This is because the sperm are 
stored in the cauda epididymis which functions poorly to maintain sperm 
viability and therefore the sperm are exposed to damaging ROS produced by 
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abnormal spermatozoa, leukocytes or immature spermatozoa which have 
also been related to an increase in DNA fragmentation. Immature 
spermatozoa produce ROS due to the cytoplasmatic content in the proximal 
droplets that can damage the DNA of mature sperm (Ollero et al. 2001). 
 
Studies on intake of caffeine (found in coffee, tea, chocolate and some soft 
drinks, particularly cola-containing beverages) and semen quality have shown 
contradictory results. Some suggested no associations (Oldereid et al. 1992, 
Ramlau-Hansen et al. 2008) while others found reduced sperm concentration as 
well as reduced total sperm count and motility (Sobreiro et al. 2005, Jensen et 
al. 2010). Caffeine intake has also been associated with increased risk of 
spontaneous abortions (Nawrot et al. 2003) which proves significant since 
caffeine is known to inhibit DNA repair (Genescà et al. 1992). Schmid et al 
(2007) also found an inverse correlation between caffeine consumption and 
sperm DNA fragmentation . 
 
The intake of certain dietary and supplementary vitamins and antioxidants also 
seems to play a role in sperm DNA fragmentation. A rich daily dietary intake of 
antioxidants, such as vitamin C, vitamin E and β-carotene, has been proposed as 
an alternative to improve male reproductive capacity by reducing the extent of 
oxidative damage (Song et al. 2006). Several studies have shown an 
improvement in the degree of sperm DNA fragmentation and/or pregnancy rate 
following a course of such therapy (Greco et al. 2005, Greco et al. 2005, 
Tremellen et al. 2007). 
 
Another important lifestyle-dependent factor that adversely affects 
spermatogenesis is obesity. Several studies have shown up to a threefold higher 
incidence of obesity in infertile men than in those with normal semen quality 
(Magnusdottir et al. 2005, Hammoud et al. 2008). A body mass index (BMI) of 
more than 25kg/m2 was associated with an average 25% reduction in sperm 
count and sperm motility (Jensen et al. 2004, Kort et al. 2006). Meta-analysis of 
31 studies showed a negative relationship for testosterone, sex hormone 
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binding globulin and free testosterone with increased BMI, however no 
evidence was found of an association between increased BMI and semen 
parameters (MacDonald et al. 2010). 
 
Although further work is needed in this area, it is very likely that the lifestyle 
factors previously mentioned, as well as others yet to be studied, play a role in 
the aetiology of sperm DNA fragmentation. 
 
4.2.2.4.4 Epigenetics 
 
 
Concern about the damage that environmental exposures may inflict on sperm 
chromatin dates back at least to the period immediately after the Second World 
War, when large numbers of men were exposed to high levels of radiation (Neel 
et al. 1990). Today, there is increasing evidence to suggest that environmental 
factors such as chemical, nutritional and physical factors, have the potential to 
affect the epigenetic process of spermatozoa and alter gene expression (Dada et 
al. 2012). Epigenetics refers to changes in the phenotype caused by mechanisms 
other than changes in DNA sequences (Wolffe et al. 2000). Depending on the 
nature of the chemicals, they may directly target the DNA, induce oxidative 
stress, or modify epigenetic elements. Epigenetics play an important role in 
male infertility with studies showing a negative effect on processes that control 
implantation, placentation and fetal growth (Dada et al. 2012). 
 
Several investigations in the last few years have examined the relationship 
between exposure to environmental chemicals and epigenetic marks. Two 
major markers of epigenetics are DNA methylation and post-translational 
histone modifications (Bollati et al. 2010). DNA methylation plays an important 
role in the maintenance of genome integrity by silencing repetitive DNA 
sequences (Hedges et al. 2007) and histone modifications, such as acetylation, 
methylation, ubiquitylation and phosphorylation, have emerged as the main 
players in epigenetic regulatory mechanisms (Bollati et al. 2010). 
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Most studies have focused on DNA methylation, as it is the easiest epigenetic 
mark to study. Nutrition during early development can influence DNA 
methylation because one-carbon metabolism is dependent on dietary methyl 
donors and on co-factors such as choline, folic acid and vitamin B-12 
(MacLennan et al. 2004). The availability of dietary methyl donors and cofactors 
is therefore critical during development. The epigenetic change caused by a 
decrease in DNA methyltransferase activity (Lillycrop et al. 2007) can be 
prevented by folate supplementation (Lillycrop et al. 2005). In postnatal life, it 
has been reported that a diet deficient in methyl donor can permanently affect 
the expression of insulin-like growth factor 2 (IGF2), resulting in growth 
retardation (Waterland et al. 2006). This suggests that the effects of nutrition 
during postnatal development can also permanently alter the epigenetic 
regulation of imprinted genes. The impact of diet, nutrients or drugs on early 
epigenetic programming must therefore be seriously considered in order to 
achieve a directed epigenetic regulation in spermatogenesis (Dada et al. 2012). 
 
The link between sperm DNA damage induced by human occupational or 
therapeutic exposures and progeny outcome has proven difficult to establish. 
Although radiotherapy and chemotherapy used to treat cancer is known to 
adversely affect the integrity of sperm DNA, there is little evidence for an impact 
on the health of their offspring (Winther et al. 2009). However, failure to detect 
a relationship may be a consequence of in adequate sample size. According to 
animal studies, it is clear that paternal exposure to either irradiation or anti- 
cancer drugs results in sperm with altered chromatin integrity and impacts on 
progeny outcome. This is manifested as an increase in pre- and post- 
implantation loss, external malformations and altered behavior, not only in the 
first generation but also in subsequent generations (Hales et al. 1986, Auroux et 
al. 1990, Crews et al. 2007). It is therefore possible that the high rate of 
spontaneous miscarriage in human populations may suggest the relationship 
between effects of common exposures on the quality of sperm DNA and an 
increase in abnormal pregnancy (Delbès et al. 2010). 
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Abnormalities in the development of embryos sired by males having an altered 
methylation pattern in their spermatozoa due to treatment with 5-azacytidine, 
a chemotherapeutic agent for acute myelogenous leukemia (Doerksen et al. 
1996, Oakes et al. 2007), strongly suggests that DNA methylation may be 
related to infertility and progeny outcome. However, the extent to which 
external factors (drugs, environmental exposures) can modulate the histone 
composition of sperm nuclei, still remains unclear. Animal models have made it 
possible to correlate sperm DNA damage with traditional parameters of 
progeny outcome such as litter size, pre- and post-implantation loss and 
external or internal malformations. However, such parameters are not sensitive 
enough to determine the potential impact of the exposure to drugs or 
environmental factors on post-natal and adult end-points such as 
neurodevelopment, immune competency or normal reproductive function 
(Delbès et al. 2010) some of which may be expected outcomes as a result of 
epigenetic modifications. 
 
Knowledge of genetic and epigenetic modifications of germ cells is necessary for 
the production of functional gametes and for overcoming infertility. Through 
detailed analysis of DNA methylation patterns it might reveal a new level of 
reduced fertilisation, implantation or pregnancy rates of infertile men. 
Epigenetic studies offer an important window to understanding the role of 
chemical and environmental interactions with human spermatozoa, establishing 
a direct link between the paternal sperm chromatin integrity and the health of 
future generations. 
 
4.2.2.5 DNA Repair 
 
 
The genome of cells is protected by mechanisms collectively known as DNA 
repair activity. Such activity is particularly important at the beginning of human 
life, especially in fertilisation and embryonic development. DNA repair activities 
are a number of processes that allow the cell to identify and then correct 
damage to DNA molecules. There are three options for a cell that is facing DNA 
damage: The first is to activate apoptosis, leading to cell death (Jurisicova et al. 
2004). The second option is to tolerate the lesion, however this may lead to 
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mutations and eventual carcinogenesis in the next generation. And thirdly, the 
more preferred option, to repair the lesion. 
 
However, spermatozoa differ from somatic cells by two main characteristics; 
Protamination and absence of DNA repair (González-Marín et al. 2012). DNA 
repair in spermatozoa is terminated as transcription and translation stops post-
spermiogenesis, so these cells have no mechanism to repair the damage that 
occurred during their transit through the epididymis and post-ejaculation. 
Oocytes and early embryos have been shown to repair sperm DNA damage, so 
the effect of sperm DNA fragmentation depends on the combined effects of 
sperm chromatin damage and the capacity of the oocyte to repair it (González-
Marín et al. 2012).  Further investigation on the repair capacity of the oocyte of 
damaged spermatozoa is crucial since unrepaired or mismatched DNA repaired 
may give rise to undesirable problems of embryo cleavage and development.  
 
There are a variety of known DNA repair systems that help to eliminate cells 
containing damaged DNA, unless they have already been eliminated via 
apoptosis. Some of these repair systems include; nucleotide excision repair 
(NER) via excinucleases, base excision repair (BER) via DNA- N-glycosylases, 
homologous recombinational repair (HR) and mismatch repair (MMR), which 
includes correction of insertions and deletions (Ménézo et al. 2010). Among all 
DNA repair mechanisms, DNA MMR genes play a critical role in the 
maintenance of genetic integrity, meiotic recombination and gametogenesis, 
whereby malfunction has been associated with de novo genetic disorders, 
developmental and morphological defects, cancer and miscarriage (Kunkel et al. 
2005). Based on their important physiological functions, the MMR genes are 
good candidate genes for explaining male infertility. Analysis of polymorphic 
markers in candidate genes have also helped to aid the understanding of 
aetiology of, and susceptibility to, male infertility (Tuttelmann et al. 2007, 
Carrell et al. 2011). 
 
Single stranded DNA damage is of little biological consequence when referring 
to cell death, and in fact the DNA strand can serve as a template for immediate 
repair. In contrast, DNA breaks in both strands are more difficult for cells to 
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repair and are considered to be the most dangerous and severe types of DNA 
damage (Lawrence et al. 2013). This is because double-strand breakage induces 
chromosomal instability and failed rearrangements (Ménézo et al. 2010). Cells 
however, contain many different mechanisms for repairing these breaks. Each 
mechanism is associated with a different risk of sequence changes at the repair 
site and errors in repair of double-stranded breaks (DSBs) can generate small 
deletions and/or insertion mutations, as well as chromosome translocations 
and genomic instability (Valerie et al. 2003). 
 
Proteins involved in searching for DNA DSBs appear to decide whether the 
damage is to be repaired or if apoptosis is more appropriate. If repair is 
required, a large number of proteins involved in homologous recombination 
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repair, single-strand annealing or nonhomologous end-joining (NHEJ) repair set 
to work (Valerie et al. 2003, Preston et al. 2006). The latter is one of the major 
pathways that repairs DSBs in DNA (Wei et al. 2013) and does not require much 
homology but often leaves additions, insertions and other sequence alterations 
at the repair site (Preston et al. 2006). Single-stranded annealing makes use of 
duplicate sequences that line the break in making the repair. If any sequence 
between these duplicate sequences, or if one copy of the duplicate sequence is 
lost, this may result in a loss of vital genetic information at the repair site. 
Homologous recombination repair involves the use of the sister chromatid or 
homolog and therefore cannot be used in repair of the Y chromosome or the X 
chromosome in a spermatozoon during spermatogenesis (Preston et al. 2006). 
 
The relatively high frequency of Y chromosome deletions – that is, the deletions 
of a sequence of DNA located on the male sex chromosome, indicates that the Y 
chromosome is particularly susceptible to the spontaneous loss of genetic 
material. The nature of this susceptibility remains speculative however, one 
possibility may relate to the instability of the Y chromosome as a result of high 
DNA damage in the spermatozoa (Aitken et al. 2001). The Y chromosome is 
particular vulnerable to DNA damage, partly because of its genetic structure and 
partly because it cannot correct double-stranded DNA deletions by homologous 
recombination. The DNA fragmentation that appears to be commonplace in 
spermatozoa (Aitken 1999) has the potential to generate deletions as the 
chromatin unravels at fertilisation. Any DSBs would normally be repaired by 
homologous recombination in the few hours that elapse between fertilisation 
and the initiation of the first cleavage division. However this repair mechanism 
cannot apply to the nonrecombining region of the Y chromosome, where the 
vital spermiogenesis genes are housed and therefore it is impossible for 
recombination repair. Moreover, the fact that such damage to the Y 
chromosome frequently results in infertility might be regarded as another 
safety mechanism that serves to limit the extent to which mutations are 
propagated in the germ line. Although the oocyte is capable of repairing single- 
stranded breaks fully, it is not as successful with double-stranded breaks. As a 
result, these mutations are fixed in the germ line, having the potential to block 
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embryo development or impact upon the health and wellbeing for the resulting 
child. Thus, the oocyte cannot be relied upon to ‘fix’ all problems associated 
with sperm DNA. 
 
Studies have also reviewed spermiogenesis as an important source of genomic 
instability. Spermiogenesis in fact, may be the most crucial period of 
spermatogenesis because, despite their haploid character, spermatids must 
resolve these programmed DSBs by the error-prone NHJE DNA repair 
mechanism. Given the limited repair capacity of the oocyte, idiopathic cases of 
infertility or embryo loss may be understood by a better knowledge of the 
chromatin steps in spermiogenesis. Further investigation should provide 
important clues regarding the genetic consequences of the endogenous DNA 
strand breaks and repair in spermatids (Leduc et al. 2008) as well as focus on 
the nuclear events associated with spermiogenesis as a potential source of 
genetic instability and reduced fertilisation potential of the mature male gamete 
(Leduc et al. 2008). 
 
A recent report using a mouse model, sheds new insight into stage-specific DNA 
repair mechanisms (Marchetti et al. 2015). The study demonstrates that 
spermatogenic phase-specific chemical dosing induces DNA damage that 
remains seemingly undetected by sperm cell repair machinery. Using melphalan 
(MLP), an alkylating agent used in chemotherapy, sperm cell DNA damage was 
induced during meiosis. DNA lesions persisted through active DNA repair 
phases of spermatogenesis and remained unchanged through the 
spermatogenic phases. This damage continued in mature sperm, successfully 
achieving fertilisation. Oocyte DNA repair machinery that attempted to repair 
the lesions however were ineffective since the MLP-induced DNA lesions were 
not identified until the metaphase after fertilisation. These findings suggest 
health implications especially for male patients receiving chemotherapies such 
as MLP, putting them at risk for mutagenic impacts on their sperm production. 
The vulnerability of both sperm and eggs to such agents demonstrates that 
exogenous chemicals have discernable effects on sperm genomic integrity. With 
sperm DNA lesions persisting silently until the first DNA replication in the 
44  
zygotic cycle, sperm DNA repair mechanisms do not appear to overcome these 
mutagenic impacts and therefore do not impair the sperm’s capacity for 
fertilisation but instead have significant impacts on spermatozoa and offspring. 
These findings provide new perspectives on both intrinsic actions of DNA 
repair checkpoints and on critical windows of sperm vulnerability to 
mutagenicity and toxicity (Marchetti et al. 2015). 
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4.3 Implications of Sperm DNA Damage 
 
Sperm DNA testing is being increasingly recognised as a helpful diagnostic tool 
in determining the couples’ fertility status. Numerous studies show an 
association with longer times to conceive compared with fertile couples (Spano 
et al. 2000), impaired embryo cleavage (Morris et al. 2002), higher miscarriage 
rates (Evenson et al. 1999) and also a significantly increased risk of pregnancy 
loss after IVF and ICSI (Zini et al. 2008). However, the implications of sperm 
DNA damage are even farther reaching. Given that sperm have few repair 
mechanisms and oocytes can only repair limited amounts of damage, the 
damage to sperm DNA may affect the germ line for generations (Aitken et al. 
2007). 
 
Although spermatozoa that possess a high level of DNA damage can reduce 
fertility, spermatozoa with oxidative DNA damage may still retain the potential 
to reach the oocyte and fertilise, giving rise to a live infant. Due to the high level 
of accuracy and integrity of genetic information required during reproduction 
and development, any damage to such an important molecule should be 
considered especially serious. If damaged sperm DNA is incorporated into the 
embryonic genome, it may lead to errors in DNA replication, transcription and 
translation during embryogenesis, contributing to miscarriage or a number of 
human diseases (Cooke et al. 2003) in not just one, but subsequent generations 
(Aitken et al. 2009). 
 
Studies show a strong association between the paternal effects of sperm DNA 
damage with early embryonic development through implantation (Simon et al. 
2014). Although the paternal influence of damaged chromatin was observed at 
all embryonic developmental stages, a more prominent paternal effect was 
found after embryonic genome activation had occurred. Moreover, a strong 
paternal influence on implantation and pregnancy rates was observed 
following Day 5 transfers (Simon et al. 2014). The progression of development 
from good quality Day 3 embryos to blastocysts is highly influenced by the level 
of sperm DNA damage. It was previously observed that faster dividing cleavage 
stage embryos more often develop into blastocysts (Lee et al. 2012, Knez et al. 
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2013) and are associated with higher pregnancy rates (Van Montfoort et al. 
2004). It is speculated that levels of sperm DNA damage are directly related to 
embryonic cleavage rates, such that the activation of additional DNA repair 
pathways forces delay in cell division (Bazrgar et al. 2014), resulting in a poor 
quality blastocyst (Ivec et al. 2011). Because these differences in embryo 
quality are often not apparent before Day 5, results from Simon et al. (2014) 
suggest that patients with high levels of sperm DNA damage could benefit from 
Day 5 blastocyst transfers, as oppose to Day 3 transfers (Simon et al. 2014).  
 
The advent of intracytoplasmic sperm injection (ICSI) has reduced the 
diagnostic significance of conventional semen parameters such as sperm 
concentration, motility and morphology. The ICSI technique allows patients who 
have reduced semen parameters the chance to become genetic fathers by 
bypassing most of the biological processes involved in natural conception. 
However, the advances in this particular technology may have been achieved at 
a potential cost to the offspring. There are concerns that ICSI babies will show 
an increase in sex chromosome abnormalities, based on the higher incidence of 
cytogenetic abnormalities in men who exhibit oligozoospermia and obstructive 
azoospermia and who are typical of the patient population treated with this 
procedure (Hewitson et al. 1999). Studies show that children conceived by ART, 
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particularly ICSI, have a higher incidence of disease than those conceived 
spontaneously (Sutcliffe et al. 2007, Basatemur et al. 2008). Contrary to this, 
there is also existing literature that has found no difference in the effects of 
assisted conception on the health and wellbeing of progeny and the risks that 
are associated with IVF and ICSI (Wen et al. 2012). 
 
There is also an association between poor sperm DNA integrity and diseases 
that continue into childhood, such as childhood cancers, leukaemia and autism 
(Aitken et al. 2007). A number of studies have shown major congenital 
malformations are present in 10% of ICSI children compared with 3% in 
spontaneously conceived children (Lie et al. 2005, Sutcliffe et al. 2007, Katari et 
al. 2009, Woldringh et al. 2010). Whereas other studies suggest little difference 
in the health of the two groups (Ludwig et al. 2006). Older men, who have 
higher levels of sperm DNA fragmentation appear to have higher frequencies of 
infants born with achondroplasia and Apert’s syndrome, schizophrenia and 
even Alzheimer’s disease (Malaspina 2001, Wyrobek et al. 2006). It is thus 
possible that younger men with high levels of DNA fragmentation may also have 
an increased risk of passing on the mutations associated with these diseases. 
 
Oocytes fertilised by sperm that contain damaged DNA do not seem to have a 
very good chance of developing into a live infant (Morris et al. 2002, Tomsu et 
al. 2002, Henkel et al. 2004, Benchaib et al. 2007), perhaps due to the inability of 
the developing embryo to successfully translate the paternal genome. 
Fortunately for patients this seems to act as a safe-guard against the birth of ill- 
affected infants following ART. However it is inevitable that there will continue 
to be embryos created and infants born, from spermatozoa that possessed DNA 
damage. In order to ensure that only spermatozoa with optimum quality are 
included in treatment, new methods need to be developed that will more 
accurately diagnose and select individual spermatozoa with damage-free DNA 
prior to ART procedures, in particular, ICSI. 
 
Current sperm selection techniques, such as density gradient centrifugation 
(DGC) and swim-up, are the main components of ART procedures. Although 
they are effective in selecting motile and morphologically normal sperm, other 
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sperm characteristics such as apoptosis, DNA integrity, membrane maturation 
and ultrastructure are not directly targeted by these routine sperm preparation 
techniques (Said et al. 2011). Based on different approaches for targeting 
functionally competent and intact spermatozoa, several advanced sperm 
selection methods have been described. These include electrophoretic 
separation, magnetic-activated cell sorting (MACS), microfluidics, 
intracytoplasmic morphologically selected sperm injection (IMSI) and 
hyaluronic acid (HA) binding (Sakkas 2013). Although these different 
approaches aim at including only mature, non-apoptotic, DNA intact 
morphologically normal spermatozoa during IVF or ICSI, they vary in terms of 
instrumentation and time required. All advanced sperm selection methods 
involve sperm manipulations that are more elaborate and time consuming than 
the routine sperm preparation techniques currently used. These added 
technical steps and processing times warrant careful assessment of some safety 
aspect since prolonged sperm exposure to non-physiologic conditions may 
induce iatrogenic damage (Homa et al. 2015). 
 
Despite this, there have been some studies that show encouraging fertilisation 
and pregnancy results following IVF and ICSI after the use of MACS (Rawe et al. 
2010), HA binding (Tarozzi et al. 2009, Parmegiani et al. 2010) and IMSI (Mauri 
et al. 2010). However it should be noted that the number of patients assessed 
were limited. More research is needed to identify which cases of infertility, if not 
all, will benefit from the application of these selection methods. Care should be 
taken to investigate safety and efficacy aspects of advanced sperm selection 
methods before their widespread implementation in ART (Said et al. 2011). 
 
Now with the aid of advances in assisted reproduction, fertilisation can be 
achieved in vitro with spermatozoa that would have otherwise been rejected in 
vivo. As a result, the importance of finding new ways to evaluate the DNA 
quality of male gametes before they are used clinically is crucial. 
49  
4.4 Methods for Determining Sperm DNA Damage 
 
In recent years, the rapid advance of molecular biology has resulted in 
numerous techniques to assess DNA and chromatin quality. Criticisms have 
been made that the results from these tests are not equivalent. This is to be 
expected because, although each test evaluates sperm quality, each may be 
elucidating a different aspect of DNA damage. There are four primary methods 
for detecting sperm DNA damage include the sperm chromatin structure assay 
(SCSA), Sperm Chromatin Dispersion Assay (SCDA) also know as the Halo test, 
the comet assay and the TUNEL assay. These assays have been shown to have 
strong prognostic power in predicting successful treatment of male infertility 
(Evenson et al. 2002, Agarwal et al. 2012). 
 
4.4.1 SCSA 
The sperm chromatin structure assay measures the susceptibility of sperm 
DNA to acid or heat-induced DNA denaturation in-situ. The SCSA uses acridine 
orange staining to label the double stranded DNA with green and the single 
stranded DNA with red. The method is based on the principle that 
abnormalities in chromatin structure are reflected in the degree to which the 
DNA can be denatured. It has been demonstrated that the more normal the 
sperm DNA and chromatin, the stronger and therefore the more resistant it is 
to denaturation (Evenson et al. 2002). A significant advantage of this assay is 
the simultaneous measurement of two important fertility- dependent factors; 
DFI and the presence of immature sperm nuclei with abnormal proteins and/or 
altered protamine/histone ratios (Lewis et al. 2013). 
 
Some published studies relating to SCSA (Evenson et al. 1999, Bonde et al. 2003, 
Saleh et al. 2003) have demonstrated that DFI levels correlated negatively with 
fertilisation rate and embryo quality after IVF and ICSI. In addition, Payne et al. 
(2005) reported lower fertilisation rates with higher sperm DFIs and that 
cleavage rates correlated negatively with HDS, but not with DFI. In contrast to 
these reports, several other investigators Larson-Cook et al. (2003) have shown 
that fertilisation rate and cleavage rate were not significantly related to SCSA 
parameters. Overall there are conflicting reports in the literature as to the 
correlation of SCSA parameters with predicting the outcome of fertilisation and 
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pregnancy rates (Chohan et al. 2006, García‐Peiró et al. 2011). 
Although SCSA is technically much less demanding than any other DNA 
fragmentation test as it can be conducted on fresh and frozen-thawed semen 
within minutes rather than hours, it does involve very expensive equipment. 
This is because the software associated with SCSA has been patented and 
therefore incurs an additional cost. Also SCSA only provides a measure of the 
potential DNA damage of sperm as it is incapable of quantifying single-stranded 
and double-stranded DNA breaks directly. 
 
  4.4.2 SCDA 
Similarly to SCSA, SCDA also bases the detection of sperm DNA fragmentation on 
the denaturing capacity of the sperm chromatin. This particular test assesses the 
capacity of sperm chromatin to form dispersion halos and allows differentiating 
the non-fragmented spermatozoa (with halo) from the fragmented spermatozoa 
(without halo) to be examined.  Like other methods, studies showing the 
infertility cut-off value for the SCDA have been performed (Nunez-Calonge et al. 
2012, Ribas‐Maynou et al. 2013). The cut-off, sensitivity and specificity results 
obtained by Ribas‐Maynou et al. (2013) did not differ from previously published 
work (Nunez-Calonge et al. 2012, Ribas‐Maynou et al. 2013). Although many 
studies reported different clinical values, only few studies have proved a 
correlation between TUNEL, SCSA and SCD (Chohan et al. 2006, García‐Peiró et 
al. 2011). 
 
4.4.3 Comet Assay  
 
The comet assay has the unique feature to distinguish between both single- and 
double-strand DNA breaks when it is performed under alkaline or neutral 
conditions. It is based on nuclear decompaction followed by electrophoresis to 
assess DNA fragmentation in individual sperm cells (Lewis et al. 2013). Clinical 
cut-off values for male infertility, assessing Comet tail DNA and percentage of 
fragmented spermatozoa have been published using the alkaline Comet assay 
for both total semen sample (Simon et al. 2011, Ribas-Maynou et al. 2012) and 
also differentiating swim-up sperm cells (Simon et al. 2011). Furthermore, 
Ribas‐Maynou et al. (2013) demonstrated a clinical association of double 
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stranded DNA breaks assessed by the neutral Comet  assay with recurrent 
miscarriage risk in couples without female factor, showing that differences in 
the DNA break type can have different implications for human reproduction 
(Ribas-Maynou et al. 2012). 
 
The comet assay is highly reproducible and since it requires a much smaller 
number of cells for analysis than other tests, it is suitable for measures of 
testicular and olgiozoospermic sperm samples where cells are scarce (Lewis et 
al. 2013). 
 
A major advantage of this assay is that it is very sensitive and is able to detect 
the degree of DNA damage in an individual spermatozoon rather than a 
percentage of damaged spermatozoa in a whole sample (Lewis et al. 2013). This 
particular assay seems to have a higher sensitivity perhaps due to the 
electrophoresis, increasing the detection of DNA breaks when compared to 
other DNA damage tests. Through ROC analysis, one study showed that the 
comet assay shows values up to 100% of spermatozoa with DNA fragmentation 
in some infertile patients. However other DNA damage tests might not even 
reach this value. This data suggests that different methodologies might be 
detecting different aspects of DNA breaks directly (Henkel et al. 2010). 
 
The comet assay also requires trained researchers to perform it optimally and 
results can vary from lab to lab. Like the SCSA, the comet assay would benefit 
from the standardisation of protocols and instruction from researchers who 
have used it extensively (Simon et al. 2010). 
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4.4.4 TUNEL Assay 
 
 
Among the different types of assays available to determine real ‘actual’ DNA 
damage, the TUNEL assay is one of the oldest. The TUNEL assay directly 
measures sperm DNA damage and is based on the addition of fluorescence- 
labeled nucleotides, namely deoxyuridine, on free 3’ –OH ends of single- 
stranded and double-stranded DNA breaks. Therefore measuring definite end- 
points, referred to as the ‘actual’ DNA damage. The TUNEL and SCSA assays 
correlate well (Evenson et al. 2006), however they are determining different 
aspects of sperm function (Henkel et al. 2010, Mitchell et al. 2011). Briefly, the 
technique involves fresh or frozen-thawed semen samples, fixed to a slide, 
permeabilised and stained before being processed by flow cytometry or 
microscopically with either fluorescent or colourimetric labels. The ratio of 
damaged to total nuclei gives the percentage of sperm with DNA fragmentation. 
 
The TUNEL assay has been well proven as a valuable tool in the assessment of 
male fertility potential and prediction of ART outcome. Robinson et al. (2012) 
analysed the different types of assays used to assess DNA damage and found 
that the miscarriage association was the strongest for the TUNEL assay. In 
terms of IVF, a meta-analysis of nine IVF and 11 ICSI studies by Zini et al. (2009) 
showed a modestly increased chance of pregnancy after IVF in cases where the 
proportion of DNA-damaged spermatozoa was below the threshold value 
(<20%) as reported by Ribas-Maynou et al (2013) for TUNEL . 
 
Although the assay has been regarded as being precise and reproducible 
(Muratori et al. 2010) the only real disadvantage is the costly equipment 
required if using fluorescence activated cell sorting (FACS), however this 
can easily be avoided through the use of florescence microscopy. 
53  
4.4.2 Limitations of Current Protocols 
 
 
The TUNEL assay has been widely used because it measures a definitive end 
point (the presence of free 3’hydroxyl groups), is not technically challenging 
and unlike the SCSA assay, does not require flow cytometer maintenance (Lewis 
et al. 2008). However, the current assay is still not the most sensitive assay due 
to some technical specifics (Mitchell et al. 2011) . For example, the TUNEL assay 
relies upon the ability of a protein, a terminal transferase, to access DNA strand 
breaks and catalyse the insertion of labeled bases. However the access of this 
protein can be restricted due to the tightly compacted nature of sperm 
chromatin in these highly specialised cells. 
 
The structure and stability of the chromatin is reinforced by the creation of 
intra- and inter-molecular protamine disulphide bonds during epididymal 
transit (Balhorn et al. 1992, Vilfan et al. 2004). Therefore a strategy needs to be 
implemented which will relax the chromatin and allow the terminal 
transferases to access the DNA strand breaks that are deep within the sperm 
nucleus. 
 
It has been discovered recently that pretreating the samples with a small 
molecular mass reducing agent, DTT, has shown to effectively relax the 
chromatin structure of mammalian spermatozoa by breaking the disulphide 
bridges between adjacent protamine molecules (Codrington et al. 2007). By 
allowing further access to the DNA breaks, it will significantly enhance the 
sensitivity of the TUNEL assay (Mitchell et al. 2011). More investigation is 
needed to formally adapt this strategy into the TUNEL assay for use with human 
spermatozoa. 
 
Another aspect of this assay, which has not been formally investigated in 
previous publications, is the impact of sperm viability on the TUNEL assay. In 
addition to chromatin compaction, TUNEL assays are also profoundly 
influenced by the vitality of the spermatozoa. While cell death via apoptosis-like 
cascades is undoubtedly associated with the induction of DNA fragmentation 
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(Shen et al. 2002, Agarwal et al. 2005) the reverse is also true: DNA 
fragmentation can appear as a consequence of cell death as well as its’ cause. 
Therefore it is evident that the assay requires a simultaneous assessment of 
measuring both cell viability and DNA strand breakage in human sperm 
populations (Mitchell et al. 2011). 
 
Apart from the general clinical value of the TUNEL assay, which has been shown 
repeatedly (Aitken et al. 2010) (Henkel et al. 2004, Sharma et al. 2010) the 
technical standardisation and proper clinical evaluation of the TUNEL assay are 
essential. Nevertheless, despite the advantages of the TUNEL assay and the 
efforts in its standardisation, more work is needed in order to eventually 
establish a robust, clinical test system to determine male infertility. 
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4.5 Methods for Detecting Oxidative Stress and Oxidative Damage 
 
 
4.5.1 Detection of 8-oxoguanine 
 
 
In nuclear and mitochondrial DNA, 8OHdG is one of the predominant forms of 
oxidative damage formed through the action of ROS attack on nucleic acids, and 
has therefore been widely used as a biomarker for detecting oxidative stress 
(Valavanidis et al. 2009). This biomarker has been selected as a representative 
of oxidative DNA damage due to its high specificity, potent mutagenicity and 
relative abundance in DNA (Floyd 1990). The 8OHdG has not only been used to 
estimate the oxidative DNA damage in humans but also as a risk factor for many 
diseases including cancer (Valavanidis et al. 2009). 
 
Detecting 8OHdG in tissues, cells and bodily fluids has initially been challenging 
as it requires the use of high performance liquid chromatography (HPLC) and 
electrochemical detection or gas chromatography-mass spectrometry (GC/MS) 
(Shen et al. 2000). More recently, a kit has become available which contains a 
fluorescence-labeled binding protein with high avidity and specificity for 
8OHdG, enabling 8OHdG detection using FACS or fluorescence microscopy (Kao 
et al. 2008) 
 
4.5.2 Localising Oxidative Stress in the Body 
 
 
Evidence of oxidative stress (OS) in the form of biomarkers such as 8OHdG 
can be assessed in many different tissues and body fluids such as urine, 
serum and seminal plasma. 
 
The oxidised nucleoside of DNA, 8OHdG, is the most frequently detected and 
widely studied DNA lesion. Its urinary level is used as a good biomarker of 
cellular OS. Numerous studies have indicated that urinary 8OHdG not only is a 
biomarker of oxidative stress but might also be a risk factor for cancer, 
atherosclerosis and diabetes (Wu et al. 2004). For example, an elevated level of 
urinary 8OHdG has been detected in patients with various cancers (Yano 
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et al. 2009). In human atherosclerotic plaques, there were increased amounts of 
oxidatively modified DNA and 8OHdG (Nakajima et al. 2012). Elevated urinary 
8- OHdG and leukocyte DNA were also detected in diabetic patients with 
hyperglycemia, and the level of urinary 8OHdG in diabetes correlated with the 
severity of diabetic nephropathy and retinopathy (Kundu et al. 2014). There are 
various methods used for localising 8OHdG in the tissue and urine, these include 
high-performance liquid chromatography (HPLC) with and without extraction 
(Zhang et al. 2013), and using an enzyme-linked immunosorbent assay (ELISA) 
kit (Kataoka et al. 2015). 
 
Correlation analysis yields that levels of 8OHdG in serum are also positively 
correlated with OS (Tabur et al. 2014). Oxidative damage to DNA or RNA in 
blood cells was monitored by several researchers in patients with Alzheimer’s 
Disease (Mecocci et al. 2002), where significantly higher levels of 8OHdG in 
lymphocytes occurred in patients who had Alzheimer’s when compared with 
controls. Levels of serum 8OHdG were determined as an indicator of oxidant 
status in patients with papillary thyroid carcinoma before and after surgery 
(Tabur et al. 2014). This study showed severe oxidative DNA damage and 
impaired antioxidant status in papillary thyroid carcinoma patients. 
 
Oxidative stress has become an area of great concern for clinicians and scientists 
because of the fact that this pathway of programmed deterioration has also 
resulted in poor fertilisation, poor embryonic development, pregnancy loss, birth 
defects (including autism) and childhood cancer (De Iuliis et al. 2006, Tremellen 
2008, Aitken et al. 2010). Over the years, the literature on OS has increased with 
the addition of several original contributions concerning the role of OS in male 
reproduction.  
 
The detection of the levels and sources of excess ROS production in semen is 
currently not included in the routinely performed semen analysis. Reasons for this 
include mere inconvenience, cost-effective and efficient assays and perhaps the 
lack of a universally accepted analysis method. Therefore contributing to the 
widespread limitations of measuring ROS as part of a male infertility assessment.  
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There are however innate mechanisms in place to prevent OS from occurring in 
healthy males. Measures such as lifestyle changes (i.e. quit smoking, nutritional 
diet) and antioxidant supplementation; Natural antioxidants such as enzymes like 
catalase and superoxide dismutase (SOD) as well as non-enzymatic compounds 
like vitamins C and E and carotenoids, can be taken to alleviate OS (Lampiao et al. 
2012, Sharma et al. 2013). Antioxidants work by reacting with and neutralizing 
ROS, assisting in preventing OS onset and preserving the spermatozoa function 
(Sharma et al. 1996). Spermatozoa also contain the antioxidants lactoferrin and 
coenzyme Q10 (Lanzafame et al. 2009).  A third lesser-mentioned protection 
mechanism of the prostasomes from the prostate. The presence of prostasomes in 
the seminal plasma results in a decreased ability of neutrophils to produce 
superoxide radicals (Lanzafame et al. 2009). 
 
To remain healthy, a sufficient amount of antioxidants must be consumed in one’s 
diet to prevent OS from occurring (Lanzafame et al. 2009). However, in some 
patients who suffer from infertility, there may be either an overproduction of ROS 
or an underproduction of antioxidants which disrupts the intricate balance and 
results in OS. 
 
 
4.6 Assisted Reproduction for Male Infertility 
 
 
4.6.1 Intrauterine Insemination 
 
 
Intrauterine insemination (IUI) is a simple, non-invasive and relatively cheap 
method used to overcome infertility. The aim of an IUI is to increase the gamete 
density at the site of fertilisation. It is generally believed that IUI with 
homologous semen should be a first-choice treatment to the more invasive and 
expensive techniques of assisted reproduction in cases where cervical, 
unexplained and moderate male factor subfertility are suspected (Ombelet et al. 
2014). Many variables may influence success rates after IUI treatment, which is 
why sperm quality should be one of the main determinants to predict IUI 
success. 
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The fresh semen sample used in an IUI undergoes a washing process to remove 
prostaglandins, infectious agents, antigenic proteins, non-motile spermatozoa, 
leukocytes and immature germ cells. This aims to enhance the quality of the 
spermatozoa by decreasing the formation of free oxygen radicals after sperm 
preparation. The final result is an improved fertilising capacity of the 
spermatozoa in vitro and in vivo (Ombelet et al. 2014). 
 
Many factors that affect IUI outcomes have been studied, however there is no 
consensus about the optimal number of motile spermatozoa inseminated 
(NMSI) that is required for a reasonable chance of pregnancy after IUI. Cao et al. 
(2014) assessed couples who had either primary or secondary infertility for 
more than one year whereby a total pregnancy rate (PR) of 14% was obtained. 
The PR was only 4% if less than 2 million motile spermatozoa were 
inseminated, but this increased to 15% when more than 2 million motile 
spermatozoa were used. This study therefore concluded that an IUI can be 
performed when the NMSI exceeds 2 million. Other studies conducted between 
2001 and 2004 found that the PR per IUI cycle was 11.4 - 12.6%, (Group 2009) 
while further studies have also obtained poor outcomes, with PRs of only 9 – 
11.3% (Guven et al. 2008, Haim et al. 2009). Many factors that influence the PR 
following IUI have been studied, including duration of infertility 
(Zadehmodarres et al. 2009), maternal age (Zadehmodarres et al. 2009), 
number of mature follicles and number of IUI cycles performed (Dickey et al. 
2002). 
 
If the male has normal semen parameters, an IUI is useful for overcoming 
cervical barriers, ovulatory disorders and unexplained infertility. It should 
therefore be used as a first line treatment before choosing the more 
invasive and expensive procedures. 
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4.6.2 In Vitro Fertilisation 
 
 
In vitro fertilisation (IVF) refers to a technique of assisted reproduction where 
the egg and sperm are fertilised outside of the body to form an embryo, 
allowing the sperm to penetrate the egg at its own accord. This embryo is then 
transferred to the uterus to hopefully implant and become a pregnancy. IVF was 
originally developed for women with blocked fallopian tubes or missing tubes 
and is still used to treat those conditions. It is also used when infertility cannot 
be explained and with the following ovulatory or structural causes: 
 
 Problems with ovulation 
 Endometriosis 
 Fibroids 
 Polycystic ovarian syndrome 
 Cervical problems 
 
According to figures from the University of New South Wales, there were 
71,516 ART treatment cycles undertaken in Australia and New Zealand in 2013 
(Still 2015). Of these cycles, 18.2% resulted in a live delivery (the birth of at 
least one live born baby) (Still 2015). In total, 12,997 live born babies were 
born following art treatment undertaken in 2013 (Still 2015).  
 
Success rates are significantly influenced by a number of factors including: 
 Woman’s age 
 Cause of infertility 
 Response to medication and treatment 
 Sperm quality 
 Number of embryos transferred 
 Transfer and use of cryopreserved (frozen) embryos 
 
 
Consistent evidence from registry-based cohort studies (Källén et al. 2005, El- 
Chaar et al. 2009) and meta-analyses, has linked assisted conception 
involving IVF with an increased risk of birth defects (Hansen et al. 2005, 
Schieve et al. 
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2005). The associations between the use of these techniques and birth defects 
have appeared to be stronger for singleton births than for multiple births 
(Lambert 2002, Reefhuis et al. 2009). However it remains unclear whether the 
excess of birth defects after IVF may be attributable to patient characteristics 
related to infertility (Zhu et al. 2006) rather than to treatment, and whether 
the risk is similar across assisted reproductive technologies and related 
therapies (Lambert 2002, Schieve et al. 2004). In one large observational study 
using detailed Australian databases, the association between IVF and the risk 
of any birth defects was not significant (Davies et al. 2012). These findings are 
also consistent with the results of previous studies (Lambert 2002, Bonduelle 
et al. 2005). 
 
Low birth weight (LBW) and macrosomia are known to be associated with 
immediate and long-term risk to offspring health (Barker et al. 1992) and IVF 
singletons are at increased risk of these complications (Jackson et al. 2004). 
However it is now recognised that factors leading to infertility may be 
responsible for adverse perinatal outcome rather than the process itself 
(Nygren et al. 2007, Romundstad et al. 2008). Maternal characteristics, in 
particular maternal age, source of the oocyte (woman’s own or donor) and 
cervical causes of infertility are strongly associated with the risk of low birth 
weight and preterm delivery in singleton live births resulting from IVF.  In 
women who successfully have a singleton live birth with IVF, the risk of low 
birth weight is reduced in older compared with younger women and both low 
birth weight and preterm are reduced when the woman’s own embryo has 
been used (Nelson et al. 2011). 
 
Epidemiologic studies have shown an increased rate of adverse perinatal 
outcomes, including small for gestational age (SGA) births, in fresh IVF cycles 
compared with frozen embryo transfer (FET) cycles (Henningsen et al. 2011, 
Kalra et al. 2011). This increase however was not seen in the donor oocyte 
population, suggesting that it is the peri-implantation environment created 
after ovulation that is responsible for these changes. (Weinerman et al. 2014)  
During a fresh IVF cycle, there are many factors affecting the endometrium and 
implantation of the embryo such as the multiple corpora lutea secreting high 
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levels of hormones. Weinerman et al. (2014) uses both animal and human data 
to demonstrate that ovulation has significant effects on the endometrium and 
embryo. As a result, potential mechanisms for the adverse effects of 
gonadotropin stimulation on implantation and placental development propose 
that a FET should be considered preferentially as a means to potentially 
decrease at least some of the adverse perinatal outcomes, including LBW and 
SGA associated with IVF.  
 
Singleton pregnancies after IVF are associated with higher risks of obstetric and 
perinatal complications when compared with those from spontaneous 
conceptions. However further research is needed to determine which aspect of 
ART causes most risk and how this risk can be minimised. 
 
4.6.3 Intracytoplasmic Sperm Injection 
 
 
Intracytoplasmic sperm injection (ICSI) has revolutionised the field of ART to 
not only enable men with severe testicular dysfunction to father their own 
offspring but also allows couples with unexplained infertility a greater chance 
of success. This is possible because the technique involves the direct injection 
of a single sperm into each oocyte, bypassing many barriers characteristic of 
natural fertilisation including penetrating the oocyte and enabling gamete 
interaction (Figure 4.6). The decision as to which sperm is selected is up to 
the embryologist and is based on motility and morphology of the sperm. The 
sperm chosen for ICSI may be isolated from a fresh ejaculated sample or 
testicular tissue from men with obstructive and non-obstructive azoospermia. 
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Figure 4.6 Intracytoplasmic Sperm Injection Technique 
 
 
A) A glass-holding pipette anchors the oocyte at the 9 o’clock position wile a beveled glass pipette 
containing an immobilised spermatozoon is pushed through the zona pellucida and against the oolemma; 
the polar body is kept at the 12 o’clock position to avoid potential damage to its adjacent meiotic spindle. 
B) The pipette containing the spermatozoon is softly pierced into the oolemma, creating a deep channel. C) 
Upon protruding the oocyte membrane, the sperm is then released at the 9 o’clock position near the 
opening of the pipette and a small amount of cytoplasm is aspirated while paying close attention to 
minimising the amount of medium released. Light suction is applied during withdrawing the injection 
pipette to allow the oolemma to reseal. D) A successfully injected oocyte with the spermatozoon in place. 
Image taken from Palermo et al (2012). 
 
 
Over the years, embryologists have gained more experience and expertise in the 
ART laboratory in performing ICSI as well as improved microscopes, new 
culture media for the sperm and oocytes and updated incubators for culturing 
the embryos, which all play crucial roles towards improving success rates 
following treatment. The first human pregnancies from ICSI were established 
only in 1992 and since then, hundreds of thousands of ICSI babies have been 
born (Palermo et al. 2012). 
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Meta-analysis studies suggest that the use of ICSI has increased fertilisation 
rates in couples with well-defined unexplained infertility (Johnson et al. 2013). 
ICSI is the most effective procedure in treating male factor infertility providing 
consistent fertilisation rates of over 70% of the treated oocytes independently 
from semen parameters and source of specimen (Palermo et al. 1992, Nagy et al. 
1995, Palermo et al. 2003). However, even with ICSI, 3% of patients experience 
a failed fertilisation result of the oocytes injected as a result the male and 
female gametes failing to interact even when brought into close contact during 
insemination (Palermo et al. 2012) 
 
Using the ICSI procedure, it is possible for males with obstructive azoospermia 
(OA), non-obstructive azoospermia (NOA) and severe oligozoospermia (SO) to 
father their own offspring using non-ejaculated retrieved sperm by 
microsurgical testicular sperm aspiration (TESA) or epididymal sperm 
aspiration (MESA). A number of adverse outcomes have been suggested as a 
result of using sperm retrieved in these ways. First, TESA may result in 
extraction of immature sperm, which may lead to an increased miscarriage rate 
and adverse effects on embryo development (Buffat et al. 2006). In a more 
recent study however, this has been refuted, showing that there was no increase 
in miscarriage rates in pregnancies resulting from TESA (Kamal et al. 2010). 
 
Another supposed problem associated with the extraction of individual sperm is 
the potential use of aged epididymal sperm, which may lead to chromosomal 
errors. Ultimately, the most likely cause of adverse outcomes is the non-natural 
selection of a single sperm (ejaculated or non-ejaculated) which may lead to the 
passage of genetic defects that have caused the male infertility in the first place 
(Aittomäki et al. 2004). In a large observational study using detailed Australian 
databases, previous findings of an increased risk of birth defects among births 
conceived with ART as compared with births from spontaneous conception 
were confirmed (Hansen et al. 2002, Hansen et al. 2005, El-Chaar et al. 2009, 
Reefhuis et al. 2009). However after multivariate adjustment, although the 
association between IVF and the risk of any birth defect was no longer 
significant, the increased risk of any birth defect associated with ICSI remained 
significant (Davies et al. 2012).  
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There has been research to suggest an increased risk of congenital 
malformations in babies conceived after IVF and ICSI. This risk could be about 
30% greater when compared to spontaneously conceived children, giving a 
frequency of as high as 8-10% depending on categorisation of the 
malformations (Halliday 2012). However because of their rarity, congenital 
malformations have not been able to be studied specifically in relation to male 
infertility (Amor et al. 2009). It is still important however, as it demonstrates 
the possibility of other, unidentified, adverse outcomes that are perhaps caused 
by epigenetic errors rather than chromosomal problems (Sutcliffe et al. 2006). 
As a result, it is not clear whether congenital malformations are an ICSI specific 
problem or potentially, a male-infertility problem. 
 
In terms of obstetric outcomes, a retrospective study from Australia in 2010 
showed that singleton ICSI pregnancies have less adverse outcomes (post- 
partum haemorrhage, placenta praevia and antepartum haemorrhage) than IVF, 
although the difference is of borderline significance (Healy et al. 2010). This 
study highlighted the findings that are now emerging consistently. The fact that 
adverse outcomes are most frequently associated with fresh embryo transfers 
in stimulated cycles as distinct from embryo transfers in natural menstrual 
cycles, as is the usual case with frozen-thawed embryo transfers (Henningsen et 
al. 2011). This may therefore be a far more important predictor of outcomes 
than IVF and ICSI technologies themselves. 
 
After careful review of the literature, it is evident that there is limited 
information available pertaining to offspring outcomes attributable specifically 
to male infertility and sperm parameters. Many of the studies have a very small 
sample size for offspring, in particular offspring conceived using TESA or MESA 
spermatozoa. Overall, it appears that the origin of spermatozoa used in ICSI 
does not have a major influence on early-life outcomes for the offspring. The 
advice to parents having ICSI for any reason must include information about the 
risks associated with perinatal outcomes, particularly the increased risk of 
congenital malformations when compared to spontaneously conceived children. 
Although this may not deter parents from going ahead with ICSI, at best they 
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will be doing so with the knowledge of possible short-term and longer-term 
risks associated with ART, especially in the presence of male infertility. 
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5. Methodology 
 
 
5.1 Patient Selection and Recruitment 
 
Couples attending Fertility First for either IUI or IVF/ICSI treatment cycles were 
recruited according to the approved ethics protocol [H10458] and an informed 
consent was obtained from both the male and female patient [Appendix 3 and 4: 
Participant Information Sheet and Consent Form]. Only those couples who were 
providing a fresh semen sample and who were undertaking their 3rd cycle or 
less of the same type were eligible for inclusion, however there were no 
restrictions based on age or any other factor. The samples from some patients 
who had given consent were not able to be used due to a low sperm 
concentration, however this was not a common occurrence. Also, not all 
patients who consented provided a blood samples. An overview of what 
participation in this project involved can be seen in Figure 5.1. 
67  
Figure 5.1 Overview of participation 
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5.2 Sample Collection and Processing 
 
 
5.2.1 Blood samples 
 
 
A sample of blood was collected from the male participant on the day of fertility 
treatment by Fertility First nurses. The serum was isolated via centrifugation 
and stored at -20C and later used for mass spectrometry analysis of oxidative 
stress markers as an indicator of levels of systemic oxidative stress. 
 
5.2.2 Semen samples 
 
 
All patients were provided with instructions for Semen Sample Collection and 
were to abstain from ejaculation for a minimum of two days and a maximum of 
seven days prior to their treatment date. Samples were collected by the patient 
either in the facilities provided by the laboratory or at home. Samples collected 
off-site were delivered within the hour to the laboratory, kept at body 
temperature and transported in a special sock to ensure the sample was kept 
out of direct sunlight. Samples were collected into a sterile container whether 
by masturbation or intercourse using a Male-FactorPak sperm-friendly condom. 
Upon receiving the sample by the scientist, patients were asked to complete a 
sample collection form as proof of identity. Each sample was allocated a specific 
unique identifier upon entry into the laboratory. 
 
An overview of semen sample processing can be seen in Figure 5.2. No 
additional semen samples were required from participants as on the day of 
providing a fresh semen sample for treatment, a small, superfluous amount of 
spermatozoa was removed and used for the project. Semen samples were 
initially processed as for use in the IUI or ICSI procedure. This involved density 
gradient centrifugation (DGC) using SupraSperm [Origio, Knardrupvej, 
Denmark] to isolate the motile spermatozoa followed by washing with Sperm 
Preparation Medium [Origio, Knardrupvej, Denmark] to remove any residual 
debris and provide nutrients to support the spermatozoa and facilitate 
hyperactivation and capacitation. A portion of prepared spermatozoa was then 
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used for either IUI or ICSI. Seminal plasma, which contains no spermatozoa, is a 
waste product of the DGC process and is normally discarded. For this project 
however, the seminal plasma was collected and stored at -20C and later used 
for mass spectrometric analysis of oxidative stress markers as an indicator of 
levels of oxidative stress local to the male reproductive tract. 
 
The remaining prepared spermatozoa were then used for both existing and 
updated assay protocols for detecting sperm DNA fragmentation and 
oxidative sperm DNA damage simultaneously. 
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Figure 5.2 Overview of semen sample processing 
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5.3 Assessment of sperm DNA damage 
 
5.3.1 TUNEL Assay 
 
 
The TUNEL Assay performed has minor alterations to the original protocol as 
described previously (Tesarik et al. 2004); (Greco et al. 2005); (Huang et al. 
2005); (Tremellen et al. 2007). Following DGC, the supernatant was removed 
and the resulting pellets were smeared onto two square regions marked by a 
Dako Pen (Dako, Glostrup, Denmark) on Menzel-Glaser Polysine Slides (Menzel, 
Braunschweig, Germany) and allowed to air dry [Fig 5.3]. Two extra slides were 
prepared to serve as a negative and positive control smear as implicated in a 
clinical setting by Thomson et al. (2011). 
 
A fixative solution of 4% paraformaldehyde was added to each square region 
and the slides were then incubated at room temperature in a humidified 
chamber for 1 hour. Following fixation the slides were then washed twice with 
Phosphate Buffered Saline (PBS) to each smear and then removed from the 
chambers and placed in glass coplin jars filled with a permeabilisation 
solution (0.5%  TritonX-100 in 0.1% sodium citrate) for period of 1 hour at 
room temperature. 
 
Each slide was removed and washed thoroughly in Phosphate Buffered Saline 
(PBS) using 2 separate beakers filled with PBS to ensure the removal of all 
remaining solution. At this stage the TUNEL control slide was placed in a 
separate, small humidified chamber and 50µl of thawed DNAse solution 
applied to each smear. This slide was then incubated at room temperature for 
30minutes. All remaining slides were also placed in humidified chambers and 
PBS applied to each smear to avoid drying. 
 
TUNEL reaction mixture was prepared immediately using the In Situ Cell Death 
Detection Kit – Fluorescein (Roche, Mannheim, Germany). The mixture was 
made up of TdT enzyme solution with fluorescein isothiocyanate [FITC] – 
labelled deoxyuridine triphosphate [dUPT] label solution in a 1:9 ratio. PBS was 
removed from each slide and 20µl of TUNEL reaction mixture was applied to 
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each smear region. The negative control slide however, received 20µl of label 
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solution and no TdT enzyme to catalyse the reaction. The slides were 
then incubated at 37 °C for 1 hour in their humidified chambers. 
 
The slides were washed twice with the application of PBS and a working 
solution of Propidium Iodide (PI) prepared by diluting 10µl of thawed, stock 
solution in 990µl PBS. A volume of 50µl was applied to each smear once PBS 
was removed and the slides incubated in their chambers at room temperature 
for 30 minutes. 
 
At the end of this incubation, slides were again washed in PBS and a mounting 
solution was prepared. The mounting solution consists of a mixture of glycerol 
(Sigma-Aldrich, St Louis, USA) and ProLong Gold Antifade Reagent (Invitrogen, 
Eugene, US) in the ratio 7:3. A single drop of this mixture was applied to each 
smear following removal of PBS and a coverslip placed over the top. The slides 
were then ready for examination. 
 
Figure 5.3 Slide preparation 
 
5.3.2 Assessment of oxidative DNA damage 
 
 
Detection of 8OHdG was performed similarly to (Kao et al. 2008) with minor 
variations. Following DGC, the supernatant was removed and the resulting 
pellets were smeared on to two square regions marked by a Dako Pen on 
polysine slides and allowed to air dry [Fig 5.3]. The pellet remaining in the 
control tube was re-suspended in approximately 150µl PBS and 30% hydrogen 
peroxide added to the suspension in the ratio 1:9. This positive control tube was 
then incubated at 37 °C for 6 minutes to induce oxidative DNA damage. 
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Following incubation the suspension was smeared on to the positive control 
square region and allowed to air dry with the other slides. A sample of control 
not treated with hydrogen peroxide was smeared on to the negative control 
square region  [Fig 5.4]. 
 
Figure 5.4  Preparation of 8OHdG control 
 
 
A fixative solution of 4% paraformaldehyde was added to each square region 
and the slides incubated at room temperature in a humidified chamber for 1 
hour. Following fixation, the slides were then washed twice with an application 
of PBS to each smear and then removed from the chambers and placed in glass 
coplin jars filled with permeabilisation solution for a period of 1 hour at room 
temperature. Each slide was then removed and washed thoroughly in PBS using 
2 separate beakers filled with PBS to ensure the removal of all remaining 
solution before being returned to their humidified chambers and covered with 
PBS to avoid drying. At this stage, the wash solution was prepared using the 
OxyDNA Test (Biotrin, Dublin, Ireland) Kit and is a 25x concentrated Tris 
buffered saline containing thiomersal. This concentrate is diluted 1 in 10 with 
water tissue for culture to produce a working Wash Solution. 
 
The Wash Solution was then mixed with FITC conjugate solution, a fluorescence 
labeled probe also supplied in the OxyDNA test kit, in a dilution of 1 in 50. 20µl 
of the mixture was applied to each smear region. Wash solution only was added 
to the negative control region [Fig 5.5]. The slides were then incubated at room 
temperature for 1 hour and 15 minutes in their dark humidified chambers. 
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Slides were then washed twice with the application of PBS and a working 
solution of PI prepared by diluting 10µl of thawed, stock solution in 990µl PBS. 
A volume of 50µl was applied to each smear once PBS was removed and the 
slides incubated in their chambers for 30 minutes at room temperature. 
 
After the incubation period, the slides were then washed twice in PBS and a 
mounting solution was prepared. The mounting solution consisted of a mixture 
of glycerol and ProLong Gold Antifade Reagent in the ratio 7:3. A single drop of 
this mixture was applied to each smear following removal of PBS and a 
coverslip placed over the top, ready for examination. 
 
Figure 5.5 8OHdG Control Treatment 
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5.3.3 Protocol adjustments 
 
 
The protocols were performed as described above with an additional two new 
steps. 
 
1. First protocol adjustment - Addition of LIVE/DEAD stain 
 
 
Once the required amount of sample had been used for IUI or IVF/ICSI, 
LIVE/DEAD solution was then prepared and added immediately using 
LIVE/DEAD Fixable Dead Cell Stain Kit (Invitrogen, Eugene, USA). This will 
enable the discrimination between viable and non-viable cells when calculating 
the percentage of DNA damage in spermatozoa. 
 
The LIVE/DEAD Solution was prepared using 1µl Live/Dead Stain Stock and 
999µl of HEPES (SAGE, Trumbull, USA) which was made fresh every time. The 
Fixable Far Red Live/Dead Stain Stock was prepared in advanced with 50µl 
Dimethyl Sulfoxide (DMSO) to 1 x vial Live/Dead Stain Stock. The stock was 
then dispensed into eppendorf tubes in 5µl aliquots where it remained stored 
away from light at  -20 °C ready for future use. 
 
A LIVE/DEAD control obtained from other suitable left-over semen samples 
was also prepared. All samples used as a control were boiled in a water bath at 
100°C for 5 minutes and remained stored away in approximately 160µl 
aliquots at 4°C until needed. 
 
 
With the prepared LIVE/DEAD solution, 20µl was added to the patient sample 
and LIVE/DEAD control and was incubated at 37 °C for 30 minutes. 
 
2. Second protocol Adjustment – Addition of DTT 
 
 
During incubation period, 2mM Dithiothreitol (DTT) (Sigma-Aldrich, St Louis, 
USA) was prepared using 15mg of DTT with 50ml of Water for Tissue Culture. 
The DTT is shown to relax the tightly bound structure of the chromatin to allow 
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the enzyme terminal transferase to access more of the DNA and potentially 
locating more breaks.. 
 
All samples were then washed in HEPES for 5 minutes at 500g (2600rpm) and 
resuspended in 100µl of 2mM DTT. The samples were covered and incubated 
at room temperature for 45 minutes. 
 
Following this incubation, the samples were then centrifuged at 500g 
(2600rpm) and resuspended in a small amount of PBS ready to be smeared onto 
polysine slides. Two slides prepared for the updated TUNEL assay and two 
slides prepared for the updated Oxy assay. An extra slide was prepared for the 
LIVE/DEAD control. 
 
Once a fixative solution of 4% paraformaldehyde was added to each square 
region and the slides incubated at room temperature in a humidified chamber 
for 1 hour, the following steps proceeded as per original protocol for TUNEL 
and 8OHdG Assays. 
 
A minor difference will again be incurred in regards to the LIVE/DEAD control, 
whereby this control will not have any TUNEL reagents applied; it remained in 
PBS until PI was applied and continued as per normal protocol. 
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5.4 Assessment of Local and Systemic Oxidative Stress 
 
 
5.4.1 Extraction of RNA and DNA from serum and seminal plasma 
samples 
 
Nucleic acids were isolated from seminal plasma and blood serum using a 
nucleic acid isolation and purification procedure optimised by Dr De Iuliis and 
Professor Aitken, co-supervisors on this project. The purified nucleic acids were 
then analysed using LC–MS/MS for the presence of different biomarkers of 
oxidative stress (Oxidised DNA - 8OHdG and Oxidised RNA - 8OHG). 
 
Samples were taken to the University of Newcastle for batch analysis. Samples 
were prepared for RNA and DNA extraction by adding 750µl of Tizol LS reagent 
per 250µl sample. To separate each phase, the homogenised samples were then 
incubated for 5 minutes at room temperature and 200µl of chloroform per 
750µl Trizol LS was added. Samples were vortexed for 15 seconds and then 
incubated at room temperature for 3 minutes. They were then centrifuged at 
12,000 x g for 15 minutes at 4 °C. 
 
Separation was evident with 3 layers containing red phenol-chloroform on the 
bottom, an interphase and a colourless aqueous upper phase containing RNA. 
The aqueous phase was then removed into a new tube. The other phases were 
stored at  -20 °C for DNA extraction. 
 
5.4.1.1 RNA Isolation 
 
 
RNA was isolated by adding 500µl of 100% isopropanol to the aqueous phase, 
per 750µl of Trizol used for homogenisation. The samples were then incubated 
at room temperature for 10 minutes and then centrifuged at 12,000 x g for 10 
minutes at 4 °C. 
 
The supernatant was removed from the tube, leaving the RNA pellet. The pellet 
was washed with 1 ml 75% ethanol per 750µl Trizol used and vortexed. The 
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samples were then centrifuged at 7500 x g for 5 minutes at 4 °C and the 
supernatant was discarded. The remaining pellet was dried (not completely 
dried) and then resuspended in DEPC-treated water. Samples were incubated at 
60 °C for 10 minutes and then checked on the nanophotometer for absorbance 
and RNA concentration. Samples were then stored at -80 °C. 
 
5.4.1.2 DNA Isolation 
 
 
Samples were removed from the -20 °C freezer and thawed at room 
temperature. Any remaining aqueous phase was removed from the interphase 
and 300µl of 100% ethanol was added. Samples were inverted several times to 
mix and then incubated for 3 minutes at room temperature. Samples were 
centrifuged at 2000 x g for 5 minutes at 4 °C to pellet the DNA. The phenol- 
chloroform supernatant was removed and discarded. 
 
The DNA pellet was washed with 1 ml of 0.1% sodium citrate/10% ethanol, pH 
8.5 per 750µl of Trizol originally used. Samples were incubated for 30 minutes 
at room temperature with occasional mixing by inversion. Samples were 
centrifuged at 2000 x g for 5 minutes at 4 °C and the supernatant was discarded. 
This wash cycle was repeated once and twice for large pellets; 200µg. The DNA 
pellet was then re-suspended in 1ml of 75% ethanol and incubated for 10 
minutes at room temperature, mixed occasionally by gentle inversion. The 
samples were centrifuged at 2000 x g for 5 minutes at 4 °C and the supernatant 
was discarded. The pellet was dried (not completely dried) and then re- 
suspended in 8mM NaOH at a concentration of 0.2 - 0.3µg/µl. Any insoluble 
material was removed by centrifuging the samples at 12,000 x g for 10 minutes 
at 4 °C. Supernatant was transferred to a new tube and checked on the 
nanophotometer for absorbance and DNA concentration. 
 
Once the DNA and RNA was extracted from both serum and seminal plasma, the 
samples were now ready to be digested into nucleotides. 
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5.4.2 DNA and RNA Digestion 
 
 
Using new tubes, 2µg of each extracted DNA/RNA sample was made up to 30µl 
with Tris-HCl in a concentration of 100mM. Only the DNA samples were then 
heated for 3 min at 100 °C and chilled rapidly in a -80 °C freezer for 5 minutes. 
The solution of 20µl of 0.1M ammonium acetate buffer and 1µl nuclease P1 
was added to both DNA and RNA samples and incubated at 45 °C for 2 hours. A 
20µl aliquot of 40mM Trizma was added along with 1µl PDE 1 solution and 
incubated at 37 °C for 2 hours. 
 
Shrimp alkaline phosphatase was then added in a volume of 1µl and incubated 
for 1 hour at 37 °C. The samples were then heat inactivated at 65 °C for 15 
minutes and centrifuged at max speed for 30 minutes. The samples were stored 
at -20 °C. 
 
After the samples had all been digested into nucleotides, they were then ready 
to be analysed using LC–MS/MS for the presence of high levels of 8OHdG and 
8OHG. 
 
5.4.3 Liquid Chromatography and Tandem Mass Spectroscopy 
 
Once the RNA and DNA was extracted from the serum or plasma by Trizol LS 
reagent, quantified and then further digested into nucleosides/tides, the digests 
were centrifuged at 13000 rpm for 5 minutes and the supernatant was then 
transferred into new axgen tubes. 
 
Glass sample vials were then labeled and 15µl of the supernatant was then 
analysed by Triple-quad MS (AB Sciex 6500). Each standard, dG, G, 8OHdG were 
previously optimized and methods applied to the serial reaction monitor were 
run for each sample. 
 
Each sample was run over a HILIC normal phase HPLC column before online MS 
measurement. A standard curve was generated for each sample at the start and 
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end of the sample list. The transitions for both G (or dG) and 8OHdG (Or 
8OHdG) were identified and quantified with reference to the standard curves. 
The data for 8OHdG (or 8OHdG) was then normalised to correct for digestion 
efficiency corrected by the corresponding G (or dG). 
 
5.5 Assessment of Sperm Morphology 
 
 
Morphological assessment was undertaken using the Diff-Quik (ThermoFisher, 
Victoria, Australia) method as described in the WHO Manual, 5th Edition 
(2010). 
 
The semen was prepared and smeared on a slide. After drying, the slide was 
immersed in triarylmethane fixative (as provided in the Diff-Quik kit) for 15 
seconds. The excess solution was drained by placing the slides vertically onto 
absorbent paper. Slides were then sequentially immersed in a Rapid stain 
solution 1 for 10 seconds, a Rapid stain solution 2 for 5 seconds, followed by 
running tap water for 15 seconds or until excess stain was removed. 
 
When the stain dried, the slide was then viewed using oil immersion and the 
100x objective. At least 200 sperm were classified into the different 
morphological categories according to the descriptions listed in the WHO 
Manual (2010). 
 
5.6 Intrauterine Insemination 
 
Ovarian stimulation was achieved by recombinant Follicle Stimulating Hormone 
FSH (Puregon, Schering-Plough) and monitored via serum Estrogen E2 and 
Lutenising Hormone LH levels and transvaginal ultrasonography. When a single 
follicle reached the desired diameter, 5000IU of Human Chorionic Gonadotropin 
hCG (Pregnyl, Schering-Plough) was administered and IUI performed the 
following day. 
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5.7 In Vitro Fertilization and Intracytoplasmic Sperm Injection 
 
 
After 3 weeks of down-regulation by an analogue of GnRH (Lucrin, Abbott 
Laboratories) ovarian stimulation was achieved by recombinant FSH, either 
Gonal-F (Merck Serono) or Puregon and moitored via serum E2 and LH levels 
and transvaginal ultrasonography. Administration of 10,000IU of hCG (Pregnyl) 
was conducted 36 hours before oocyte retrieval to ensure all oocytes reached 
final maturity. Suitable oocytes were injected with a spermatozoon 3 hours after 
retrieval and checked for fertilisation after 18-20 hours. Suitable embryos were 
transferred on day 2, 3 or 5. 
 
5.8 Assessment of Reproductive Outcome 
 
 
Reproductive outcome was determined using both biochemical tests and 
ultrasonography and all women were followed up after their estimated date of 
delivery (EDD) as is standard practice at Fertility First. A cycle was then 
classified as successful with a serum β-hCG of ≥25 IU 18 days after ovulation or 
oocyte retrieval. This indicated that a pregnancy had been achieved. The 
pregnancy was then further assessed using ultrasonography 6 weeks following 
ovulation or oocyte retrieval to determine viability and was classified as a 
clinical pregnancy if a fetal heartbeat was detected. Pregnancy outcome was 
also obtained following the EDD. 
 
5.9 Statistical Analyses 
 
 
Spearman’s rank correlation coefficients were used to identify relationships, 
and independent/paired samples t tests used to evaluate differences between 
continuous variables. Chi-square analysis was used to evaluate differences 
between binomial variables. 
 
Percentage DNA damage results determined using both existing and updated 
assays and mass spectrometry results pertaining to local and systemic oxidative 
stress were used to construct ROC curves to determine their significance as a 
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criterion for distinguishing couples likely to achieve a positive outcome 
following assisted reproduction from those unlikely to achieve a positive result. 
A positive/successful outcome was considered as a live birth. The area under 
the curve, confidence intervals of the area, and coordinates of the curve were 
used to determine the sensitivity and specificity of different threshold values. 
Results were considered to be significant if P < 0.05. 
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6. Results 
 
 
6.1 Demographics 
 
There were 92 patients recruited for this research project. However 14 patients 
were excluded from the study due to either a decreased sperm concentration, 
incomplete sets of data obtained, or technical difficulties when performing the 
assay. Therefore, out of the 78 patients remaining, 25 had an IUI cycle and 53 
patients underwent an IVF/ICSI cycle. Key demographics can be seen in Table 
6.1. The antioxidant treatment prescribed to patients if necessary by the 
medical director includes centrum, coenzyme Q10 (50-100mg), vitamin C 
(1000mg) and vitamin E (1000mg).  
 
Table 6.1 Demographics 
 
 IUI IVF/ICSI Significance 
Previous cycles 2.0 
(0.8) 
1.0 (0.5) NS 
Male Age 37.1 
(6.4) 
38.3 (5.6) NS 
Female Age 36.2 
(5.1) 
37.2 (5.8) NS 
Significant Female Factor 1.0 
(0.5) 
1.0 (0.5) NS 
Abnormal semen 
parameters 
1.0 
(0.4) 
1.0 (0.4) NS 
 
Values are Means (Standard Deviation). NS = Not significant . Significant female factor = At least 
one of endometriosis, polycystic ovary syndrome, fibroids or tubal disease.  
Abnormal semen parameters = Reduction in at least one of concentration, motility or 
morphology. 
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6.2 Semen Parameters on day of treatment 
 
 
There were no significant differences between the IUI and IVF/ICSI treatment 
groups in terms of semen parameters [Table 6.2]. 
 
Table 6.2 Semen Parameters 
 
Factor IUI IVF/ICSI Significance 
Count million/ml 52.2 (31.7) 51.5 (38.0) NS 
(LRL = 19) 
Motility (%) 60.8 (18.9) 51.0(23.3) NS 
(LRL = 40%) 
Morphology (%) 12.0 (6.2) 12.0 (4.6) NS 
(LRL = 4%) 
Days abstinence 2.0 (1.0) 2.0 (1.3) NS 
 
Values are Means (Standard Deviation). LRL = Lower reference Limit. NS = Not significant 
 
6.3 Current Protocol Versus Updated Protocol 
 
There was no significant difference between the percentage of sperm DNA 
fragmentation obtained using the current TUNEL assay protocol and that 
obtained using the updated protocol (7.8% vs 8.8% respectively, p = 
0.335). 
 
There was also no significant difference between the mean percentage of 
oxidative sperm DNA damage obtained using the current 8OHdG assay protocol 
and that obtained using the updated protocol (14.9% vs 16.8%, p = 0.07). 
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6.4 Stability of TUNEL and 8OHdG Assays 
 
 
At initial consultation, the Medical Director will request a semen analysis, 
TUNEL and 8OHdG assay to be performed on the male. The results of these 
initial tests were obtained from each patient in order to determine stability 
of the assay over time. 
The average number of months between initial assessment of sperm DNA 
integrity at the time of semen analysis and the day of IUI or IVF/ICSI treatment 
was 7.7 months (SD 9.5). The percentage of oxidative DNA damage as 
determined using the 8OHdG assay was not significantly different between the 2 
time points (17.9% vs 17.1% respectively, p = 0.458). The percentage of sperm 
DNA fragmentation as determined using the TUNEL assay however was 
significantly lower on the day of treatment (10.4% vs 8.0% respectively, p < 
0.01). 
 
6.5 Sperm DNA damage and outcome of assisted reproduction  
 
 
When pregnancy was considered as the desired outcome of assisted 
reproduction, there were no significant differences in the mean percentage 
sperm DNA fragmentation or mean percentage oxidative sperm DNA damage 
between those couples achieving a pregnancy (IUI = 4/25, IVF/ICSI 9/53) and 
those who did not. This was regardless of which protocol was used and was 
consistent across IUI and IVF/ICSI cycles.  Embryo quality and fertilisation 
rate were not the focus of this small study, however sample collection is 
ongoing for further analysis and publication purposes. 
 
The ultimate outcome of assisted reproduction however, is a live birth and the 
mean percentage sperm DNA fragmentation as determined using the current 
TUNEL assay protocol was found to be significantly lower for those couples 
achieving a live birth following IUI (2.5% vs 10.3%, p < 0.001).  The number of 
couples achieving a live birth (IUI = 3/25, IVF/ICSI = 7/53). A ROC analysis 
was therefore performed to assess the ability of the percentage sperm DNA 
fragmentation as determined using the current TUNEL assay for predicting a 
negative outcome following IUI (ie no live birth). This analysis gave an area 
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under the curve of 0.902cm2 (P = .027) when sperm from couples achieving a 
live birth was compared to those who did not (Table 6.3). In contrast, the same 
analysis for ICSI cycles gave an area under the curve of 0.320cm2 which was 
not significant (P = .115). 
 
The coordinates of the ROC curve for live birth in IUI cycles were examined and 
a cut-off point of 3.5% current TUNEL protocol assay was selected for analysis. 
This threshold value had 100% sensitivity and 86.4% specificity for detecting 
those couples unlikely to achieve a live birth after IUI treatment. Further, rates 
of clinical pregnancy (defined as a fetal heart detected at 6 weeks gestation) and 
live births were significantly higher in the group with <3.5% sperm DNA 
fragmentation and although not significant, trends towards a higher pregnancy 
(defined as a positive serum ßhCG) rate and lower miscarriage rate were 
observed (Table 6.4). 
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Table 6.3. Comparison of sperm DNA damage in live birth and non-live birth groups by treatment type 
 
 
           IUI 
         (N = 25) 
 
 
 
IVF/ICSI 
(N = 53) 
Assay 
% 
Live 
birth 
(n =3) 
 
No live 
birth 
(n = 22) 
Sig AUC 
(95% CI) 
Live 
birth 
(n = 7) 
No live 
birth 
(n = 46) 
Sig AUC 
(95% CI) 
Current TUNEL 2.5 
(0.4) 
 
10.3 (6.6) 0.027 0.902* 
(0.78-1.0) 
10.3 
(7.0) 
7.0 (5.6) NS 0.320 
(0.9-0.55) 
Current 8OHdG 18.3 
(6.2) 
 
18.0 (8.7) NS 0.485 
(0.2-0.77) 
12.7 
(6.0) 
16.7 (7.8) NS 0.651 
(0.43-0.88) 
Updated 
TUNEL 
6.2 
(4.5) 
7.6 (3.9) NS 0.591 
(0.21-0.97) 
6.3 
(6.7) 
10.2 (7.0) NS 0.72 
(0.47-0.98) 
Updated 
8OHdG 
18.0 
(15.6) 
12.9 (8.4) NS 0.379 
(0.0- 0.83) 
15.6 
(10.7) 
15.5 (8.5) NS 0.50 
(0.23-0.77) 
Note: Values are means (SD) unless otherwise specified. *Significant P < 0.05). AUC = area under the curve. CI = Confidence 
Intervals. NS = Not significan 
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Table 6.4. Outcomes of IUI cycles using cut-off value of 3.5% sperm DNA 
fragmentation as determined using the current TUNEL assay 
 
 <3.5% DNA 
fragmentation 
>3.5% DNA 
fragmentation 
(n/N) 
 
 
P 
value 
 
Pregnancies 
 
66.7% 
(4/6) 
 
OR = 2.5, 
CI = 0.057 – 11.4 
 
36.8% 
(7/19) 
 
OR = 0.74, 
CI = 0.45 – 1.2 
 
 
NS 
 
Miscarriages 
 
16.7% 
(1/6) 
 
OR = 0.4, 
CI = 0.06 – 3.1 
 
36.8% 
(7/19) 
 
OR = 1.2, 
CI 0.8 – 1.9 
 
 
NS 
Clinical 
Pregnancies 
 
50.0% 
(3/6) 
 
OR = 5.3, 
CI = 1.6 – 17.3 
 
 
5.3% 
(1/19) 
 
OR = 0.3, 
CI = 0.05 – 1.6 
 
0.031 
 
Live Births 
 
50.0% 
(3/6) 
OR = 7.3, 
CI = 2.6 – 21.0 
 
0.0% 
(0/19) 
 
 
0.009 
 
OR = Odds Ratio. CI = Confidence intervals. NS = Non-significant 
 
 
6.6 Levels of oxidised nucleic acids in blood and seminal plasma 
 
 
Mass spectrometry (MS) was used to determine the levels of oxidised RNA 
(8OHG) and DNA (8OHdG) in both serum and seminal plasma collected from the 
patient on the day of treatment. However sample size was restricted due to a 
number of male patients not consenting to providing a blood sample on the day 
of treatment (n = 17) and some samples containing RNA and/or DNA at levels 
below that detectable by MS (n = 25). Levels of oxidised DNA in serum were too 
low to be detected for both IUI (Table 6.5) and IVF/ICSI groups (Table 6.6)
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Table 6.5 Levels of oxidised RNA and DNA in serum and seminal plasma for IUI 
groups 
 8OHG 
(Oxidised RNA) 
8OHdG 
(Oxidised DNA) 
  
Mean (SD) 
Sample 
number 
X/25 
 
Mean (SD) 
Sample 
Number 
X/25 
Seminal Plasma 
Live Birth 
No live birth 
 
0.002 (0.002) 
0.000 (0.001) 
 
3 
15 
 
0.000 (0.000) 
0.011 (0.027) 
 
3 
22 
Serum 
Live birth 
No Live Birth 
 
0.091 (0.000) 
0.014 (0.019) 
 
1 
9 
 
* 
 
* 
 
*Statistical analysis was not performed due to low sample size
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Table 6.6 Levels of oxidised RNA and DNA in serum and seminal plasma for IVF/ICSI 
groups 
 8OHG 
(Oxidised RNA) 
8OHdG 
        (Oxidised DNA) 
 Mean (SD) Sample 
# X/53 
Mean 
(SD) 
Sample 
# X/53 
Seminal Plasma 
Live Birth 
No live births 
 
0.0004 (0.0005) 
0.0010 (0.0011) 
 
5 
37 
 
0.0046 
(0.0057) 
0.0167 
(0.0526) 
 
7 
45 
Serum 
Live birth 
No live births 
 
0.0038 (0.0057) 
0.0302 (0.0423) 
 
4 
23 
 
* 
 
* 
   
*Statistical analysis was not performed due to low sample size 
 
 
6.7 Correlations between 8OHdG/8OHG in the systemic circulation 
(serum) and male reproductive tract (seminal plasma) with the levels of 
sperm DNA damage 
 
Statistical analysis using correlations was used to determine whether sperm 
DNA damage was associated with 8OHG/8OHdG in systemic circulation (serum) 
and/or the reproductive tract (seminal plasma). 
 
The percentage sperm DNA fragmentation as determined using the updated 
TUNEL assay protocol was found to be positively correlated with the level of 
8OHdG in seminal plasma (r = 0.457, p<0.05) [Figure 6.1] and the updated 
8OHdG protocol assay was highly correlated with the current 8OHdG assay (r = 
0.404, p<0.05) {Figure 6.2]. There were no significant correlations between 
serum (oxidative stress) and sperm DNA damage or with any other DNA 
parameters as shown in Table 6.6 whereby sample size was too small for 
statistical analysis, however sample collection is still ongoing.
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Figure 6.1 The correlation between 8OHdG levels in seminal plasma and the 
percentage of sperm DNA fragmentation using the updated TUNEL assay 
protocol
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Figure 6.2 The updated 8OHdG assay protocol is highly correlated with the 
current 8OHdG assay 
 
 
 
 
6.8 Relationship between 8OHdG/8OHG in the systemic circulation 
(serum) and male reproductive tract (seminal plasma) and outcome of 
assisted reproduction 
 
A successful outcome of assisted reproduction was considered to be a live birth. 
Samples tested using mass spectrometry were restricted due to a number of 
male patients not consenting to providing a blood sample on the day of 
treatment (n = 14) and some samples containing RNA and/or DNA at levels 
below that detectable by MS (n = 23). No association was found between 
systemic and reproductive tract levels of oxidised nucleic acids and ART 
outcome. 
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7. Discussion 
 
With the limitation of the conventional semen analysis being the inability to see 
beyond the basic sperm features, the TUNEL and 8OHdG assays and the 
information they provide regarding DNA integrity are currently considered a 
valuable addition to assessing fertility. It is therefore crucial to have a reliable 
procedure that accurately assesses the DNA damage of the spermatozoa. Since 
the TUNEL assay was introduced in by Gorczyca et al. (1993) several 
modifications have been made to try to improve its sensitivity and reliability 
(Mitchell et al. 2011). This present study tested two additional protocol steps 
and has demonstrated that the updated protocols for the TUNEL and the 8OHdG 
assays did not influence the percentage of sperm exhibiting fragmented DNA 
and/or oxidative DNA damage in the sample prepared and used for either IUI or 
IVF/ICSI cycles when compared to the current protocols. It did however show 
that sperm DNA damage may be due to oxidative stress in the male 
reproductive tract rather than in the systemic circulation. Ongoing 
investigations need to confirm these findings and to determine a more 
comprehensive result in regards to the role of 8OHdG and sperm DNA 
fragmentation in fertility and the impact it has on the success of ART treatment. 
 
This is the first study to report on the addition of DTT and LIVE/DEAD stain into 
the TUNEL and 8OHdG assays for assessment of DNA integrity in the clinical 
setting. Results showed that there was no significant difference between the 
percentage sperm DNA fragmentation determined using the current and 
updated TUNEL assay protocols. The difference between the mean percentage 
oxidative sperm DNA damage determined using the current and updated 
protocols approached but did not reach significance, with the updated protocol 
yielding a slightly higher percentage (14.9% vs 16.8%, p = 0.07). The trend 
towards an increased result could be due to the 8OHdG probe clumping 
together when the chromatin is condensed. When the DTT is added, it is then 
relaxing the chromatin and therefore the assay is able to flag more oxidised DNA 
base adducts. However due to the small sample size, further studies are 
necessary to confirm findings. 
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Previous reports demonstrated that the addition of DTT used in DNA 
extraction makes the chromatin of the sperm head more accessible (Mitchell et 
al. 2011) by breaking the disulphide bridges between adjacent protamine 
molecules and relaxing the tightly condensed structure of the sperm’s 
chromatin. This allows the terminal transferases to access the DNA that is deep 
within the sperm nucleus (Codrington et al. 2007).  In this study, incubation of 
spermatozoa with 4mM DTT, caused the sperm heads to swell as shown in Fig 
7.1. Studies are in agreement with this finding showing that treating 
spermatozoa with DTT causes severe chromosomal breakage, inducing 
membrane disruption (Szczygiel et al. 2002) and also causes the nucleus to 
enlarge and decondense, while the acrosomal region remains relatively intact 
(Gall et al. 1976). These results could suggest possible mechanisms for 
decondensation of the sperm nucleus after penetration of the egg. 
 
The swelling made the identification of each sperm cell more complex. 
Further work needs to be done to experimentally determine how DTT may 
best be incorporated into the assays to increase access to DNA damage while 
also limiting the disruption to the spermatic cell membrane and thus 
maintaining overall cell, and assay, integrity. 
 
Fig 7.1  Swollen spermatozoa heads treated with DTT 
 
 
 
 
 
 
 
Image taken from this project showing swollen spermatozoa heads treated with DTT 
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According to Mitchel et al (2011) the TUNEL assay was found to be highly 
correlated with sperm vitality. For this reason, we incorporated the 
LIVE/DEAD stain, which covalently binds to intracellular amine groups in non-
viable cells, into the TUNEL and 8OHdG assays in this study to determine 
whether reported levels of DNA damage are affected by the presence of non-
vital cells incapable of fertilisation. Unlike other vitality assessment methods, 
this tag remains associated with the spermatozoa during fixation and 
processing so that DNA integrity and vitality could be assessed simultaneously. 
We found that there were very few non-vital cells, likely due to the fact that the 
samples were prepared by density gradient centrifugation (DGC), a process 
designed to separate dead cells and debris from the motile spermatozoa. This 
is an encouraging result as it indicates that assessment of sperm DNA damage 
conducted following DGC is reliable in reporting DNA damage of only viable 
cells. 
 
At the time of initial consultation with the medical director, male patients are 
required to produce a semen sample for baseline assessment of semen 
parameters using standard semen analysis and assays for sperm DNA 
fragmentation and oxidative DNA damage using the TUNEL and 8OHdG assays 
respectively. The results of these initial tests provided the opportunity to 
compare baseline results with the results obtained on the day of IUI or IVF/ICSI 
treatment. The percentage of oxidative sperm DNA damage as determined using 
the 8OHdG assay was stable, with no significant difference between baseline 
and day of treatment results. The percentage of sperm DNA damage as 
determined using the TUNEL assay however, was significantly lower. It is 
standard practice for the medical director to prescribe a course of antioxidants 
in the form of centrum, coenzyme Q10 (50-100mg), vitamin C (1000mg) and 
vitamin E (1000mg).  
 
It is possible that these antioxidants have led to a reduction in the degree of 
DNA damage in the form of DNA strand breaks by the time of treatment. 
Similarly, other studies have also shown the effective contribution of 
antioxidant therapy in the clinical management of sperm DNA damage, a 
therapy that should be undertaken as a matter of urgency (Lewis et al. 2013, 
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Gharagozloo et al. 2016). We are currently exploring the adherence of patients 
included in this study to the course of antioxidants in order to conduct further 
statistical analysis. A reduction in the degree of sperm DNA damage following a 
course of antioxidant therapy also indicates that samples should be tested again 
prior to treatment so that those patient demonstrating a significant reduction in 
damage may be directed towards an IUI cycle rather than a more invasive and 
expensive ART treatment. Hence why regular review of the methods used to 
assess sperm DNA quality are necessary to ensure that the most appropriate 
ART treatment is offered to infertile couples. 
 
In terms of predicting a successful outcome following ART treatment, the mean 
percentage sperm DNA fragmentation as determined using the current TUNEL 
assay protocol was significantly lower for those couples achieving a live birth 
following IUI (2.5% vs 10.3%, p < 0.001). Using ROC analysis, a threshold of 
3.5% sperm DNA fragmentation was shown to have a good sensitivity and 
specificity for predicting an outcome of a live birth following an IUI in this 
subset of patients. This is a lower threshold than Thomson et al (2011) who 
reported 11.5% as a useful threshold for detecting those couples unlikely to 
have a successful outcome after IUI. 
 
This study also showed that for the <3.5% DNA fragmentation group, there 
were higher pregnancies and clinical pregnancies as well as decreased 
miscarriage rates (Table 6.4). This supports a large body of evidence in the 
literature, which show the significant negative relationship that sperm DNA 
fragmentation has on fertility and miscarriage, implicating the male DNA as a 
key factor during the early development of the embryo (Gandini et al. 2000, 
Irvine et al. 2000, Younglai et al. 2001). 
 
Although this was in disagreement with some authors (Tomlinson et al. 2001, 
Morris et al. 2002), it was in agreement with others who found that sperm DNA 
fragmentation rate negatively correlated with fertilisation rate after ICSI. 
Studies in particular, (Lopes et al. 1998, Benchaib et al. 2003), found that sperm 
DNA fragmentation did not vary for fertilisation rates >40%, but increased for 
fertilisation rates <40%. A possible explanation for this is that if DNA 
fragmentation is low, the oocytes are able to repair the damaged sperm 
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(Ahmadi et al. 1999). However these capacities are overloaded in cases of high 
levels of sperm DNA fragmentation. 
 
Groups using TUNEL have reported threshold values for IUI groups that range 
from 4% to 20% (Duran et al. 2002, Huang et al. 2005, Borini et al. 2006) so it is 
possible that the lack of association found between sperm DNA fragmentation 
and live birth is due to all of the patients being relatively ‘normal’ as far as DNA 
fragmentation is concerned. Most importantly, there are so many variables in 
true-life models that need to be carried out correctly in order for a live birth or 
pregnancy to occur. This includes all the barriers through which the sperm must 
pass before it fertilises the egg; therefore it is difficult to pin-point that an 
unsuccessful cycle is the result of DNA fragmentation. 
 
Alternatively, the effect of sperm DNA fragmentation on ART outcome reported 
throughout the literature may actually be due to oxidative DNA damage 
specifically, and could therefore explain these discrepancies. Several studies 
have shown that the predictive power of models using sperm DNA 
fragmentation can be significantly enhanced when oxidative DNA damage is also 
included (Simon et al. 2010, Thomson et al. 2011). 
 
Previous studies have identified a relationship between 8OHdG and clinical 
pregnancy after IUI, with significantly lower levels of 8OHdG found in the sperm 
from couples who achieved a clinical pregnancy. Thomson et al (2011) 
indicated that a threshold value of 11.5% 8OHdG selected through ROC analysis 
proved useful for detecting those couples unlikely to have a successful outcome 
following IUI. 
 
Interesting though that neither sperm DNA fragmentation nor 8OHdG had any 
relationship with clinical pregnancy following ICSI which confirms many other 
reports (Huang et al. 2005, Li et al. 2006, Simon et al. 2010) but disagrees with 
some (Benchaib et al. 2003, Virro et al. 2004, Bakos et al. 2008). It is not 
surprising that DNA damage is not related to success after ICSI cycles 
considering the selection of the spermatozoa and its penetration of the egg is 
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entirely at the hands of the scientist and therefore bypasses all natural selection 
and safeguards. It is important to note that the majority of these studies either 
looked at DNA fragmentation only or reported the relationship to be with 
8OHdG only, again revealing the divide in the literature. 
 
Overall, future studies are needed to further explore the role of 8OHdG and 
sperm DNA damage in fertility and the impact it has on the success of ART 
treatment. 
 
Advancements in mass spectrometry have aided in the identification of seminal 
plasma proteins that regulate sperm function (Sharma et al. 2013). 
Improvements in proteomic approaches including higher resolution and 
sensitivity of mass spectrometry techniques have improved our understanding 
of the proteomic composition of bodily fluids such as serum and seminal 
plasma. Many of the proteomic analyses of bodily fluids have been done using 
LC-MS/MS measurements (Steen et al. 2004). 
 
Results from the mass spectrometry data in the current study showed that 
8OHdG in seminal plasma correlated with the updated TUNEL assay, suggesting 
that the origin of DNA fragmentation could potentially be caused by seminal 
plasma ROS. Previous studies are in agreement with this finding showing that 
sperm DNA damage is believed to depend on several factors including ROS 
production (Sakkas et al. 2003, Atig et al. 2013). 
 
Studies also suggest that seminal plasma ROS are responsible for single and 
double-stranded DNA damage caused by oxygen radical-induced damage 
(Sakkas et al. 2010). The extent of double-stranded DNA damage induced by 
oxygen radicals during passage of sperm through the epididymis may be 
determined not only by the levels of oxygen radicals produced by immature 
sperm, epididymal epithelial cells, or activated leukocytes, but also by the levels 
of antioxidant enzymes present in the lumen of the epididymis (Sakkas et al. 
2010). Although an increasing number of studies have identified more than 
2545 unique proteins expressed in seminal plasma, very few seminal plasma 
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proteins have been unambiguously linked to infertility (Zybailov et al. 2006, 
Rodríguez Martínez et al. 2011). The role of ROS and their effect on the 
seminal plasma proteins is yet to be conclusively determined. 
 
Although sample size was small, there seems to be a trend towards lower levels 
of oxidised nucleic acids in the serum and seminal plasma of men contributing 
to a live birth in IVF/ICSI cycles. Further work needs to be done to further 
explore the origins of oxidative stress and sperm DNA fragmentation and the 
relationship between oxidative stress in the male reproductive tract and 
systemic circulation and whether such states of oxidative stress are related to 
outcome of assisted reproduction. 
 
There is an increasing awareness of the role of oxidative stress in pregnancy 
and fertility. Additionally, oxidative stress has been implicated in female 
infertility, preeclampsia (Agarwal et al. 2012), gestational diabetes (Chen et al. 
2005) preterm labour, polycystic ovarian disease, endometeriosis and fetal 
growth restriction (Potdar et al. 2009). However, there is still a lack of basic 
research in understanding how oxidative stress can have an impact on 
reproduction. Nucleic acids are modified in vivo through oxidative processes 
that yield chemically stable markers of oxidative damage. (Orhan et al. 2004). 
Perhaps simultaneous measurement of such markers may provide information 
about the nature, magnitude and origin of biochemical processes involved in 
oxidative tissue damage (Orhan et al. 2004). The main disadvantages of mass 
spectrometric techniques however are the high cost of equipment and the need 
for skilled staff for operation and maintenance. Future research is needed to 
work towards developing and validating a robust LC-MS/MS assay for 8OHdG in 
plasma, serum and other reproductive fluids. 
 
A significant strength of this study lies in the use of the outcome ‘live birth’ as 
most studies use pregnancy or clinical pregnancy as an endpoint. General 
limitations of this study include the difficulties surrounding patient recruitment 
stemming from both the drop in patient numbers due to leave taken by the 
medical director and the reluctance of male patients to provide a serum sample 
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on the day of treatment. A significant number of the seminal plasma and serum 
samples also yielded low levels of RNA and/or DNA for mass spectrometry. 
Such small sample sizes result in difficulties in drawing conclusions from the 
results. Also, due to the effect of DTT on overall cell integrity, with cell swelling 
making assessment difficult, further studies are necessary in order to optimize 
the addition of DTT to assays for assessment of sperm DNA damage. 
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8.  Conclusions 
 
Overall, there is no evidence from this study to suggest that DTT and/or 
LIVE/DEAD should be routinely incorporated into existing TUNEL or 8OHdG 
assays. In fact, the incorporation of the LIVE/DEAD stain demonstrated that 
very few non- viable sperm cells remain following DGC, thus increasing 
confidence in the reliability of the results obtained using these assays. Further 
work needs to be done on optimising the addition of DTT to assays for 
assessment of sperm DNA damage due to its affects on overall cell integrity. 
 
The percentage of sperm DNA damage as determined using the TUNEL assay 
was found to be significantly lower on the day of treatment as compared to the 
time of initial semen analysis. It is possible that the course of antioxidants 
prescribed by the medical director, has led to a reduction in the degree of DNA 
damage in the form of DNA strand breaks by the time of treatment. Such 
reductions may therefore mean that the less invasive IUI cycle may become an 
option for previously unsuitable patients. 
 
This study has also demonstrated a correlation between seminal plasma levels 
of oxidised nucleic acids and sperm DNA fragmentation, which suggests that 
sperm DNA damage may be due to oxidative stress in the male reproductive 
tract rather than systemic oxidative stress. Ongoing investigations need to be 
done to confirm these findings and further explore the role of 8OHdG and sperm 
DNA fragmentation in fertility and their impact on the outcome of assisted 
reproduction. Finally, a threshold of 3.5% sperm DNA fragmentation was shown 
to have a good sensitivity and specificity for predicting an outcome of a live 
birth following an IUI. Increased pregnancies, clinical pregnancies and live 
births, as well as decreased miscarriage rates was also associated with the 
<3.5% DNA fragmentation group in this subset of patients. 
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